| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Mar―28 |
Skin manifestations of SARS-CoV-2 Omicron variant: Clinical, pathological, and immunological insights |
Yuling Zhang, Yueming Mu, Bing Han, Rowida A. Albarmaqi, Huimin Wang, Yuemeng Zhao, Zhuang Tian, Jianxin Xia, Shanshan Li, Hong Wang, Aihua Fu, Hua Zheng, Yaping Tian |
| 2 |
[GO] |
2024―Mar―21 |
Flares and new related lesions of Hidradenitis Suppurativa following COVID-19 vaccination: A retrospective cohort study of 250 patients in Greece |
Aikaterini I. Liakou, Andreas G. Tsantes, Magdalini Kalamata, Lydia Tsamtsouri, Efthymia Agiasofitou, Soultana Vladeni, Angeliki Dragoutsou, Evangelia-Konstantina Bompou, Konstantina A. Tsante, Eleni Chatzidimitriou, Ourania Kotsafti, Stefanos Bonovas, Alexandros I. Stratigos |
| 3 |
[GO] |
2024―Mar―18 |
The role of COVID-19 vaccines in the development and recurrence of pemphigus and bullous pemphigoid |
Gaurav N. Pathak, Anurag N. Pathak, Babar Rao |
| 4 |
[GO] |
2024―Feb―24 |
The impact of COVID-19 pandemic on the number of first diagnosis and follow-up visits of patients affected by pemphigus, bullous pemphigoid, scleroderma, psoriasis and vitiligo: A single-centre experience |
Francesco Moro, Feliciana Mariotti, Anna Pira, Luciano Sobrino, Sabatino Pallotta, Annarita Panebianco, Giovanni Di Zenzo |
| 5 |
[GO] |
2024―Feb―21 |
A sharp increase in early syphilis cases in a referral hospital in Athens, Greece, 2 years into the COVID-19 pandemic |
E. Nicolaidou, K. Fouseki, V. Paparizos, O. Kotsafti, V. Vasalou, E. Daskalakis, J. Lakoumentas, A. Giannoukos, G. Emmanouil, R. Kapranou, Z. Kripouri, S. Papanikou, I. Stefanaki, A. Tagka, S. Gregoriou, E. Paparizou, A. Stratigos |
| 6 |
[GO] |
2024―Feb―01 |
Annular cutaneous sarcoidosis following COVID-19 vaccination |
José Ramos, António Silva, Ângela Roda, João Alves |
| 7 |
[GO] |
2024―Jan―13 |
De novo pemphigus vulgaris and pemphigus foliaceus development following COVID-19 infection and vaccination: Matched case-control study |
P. G. Arduino, A. A. Kubanov, A. V. Vlasova, A. A. Martynov, S. I. Svishchenko, S. Petti |
| 8 |
[GO] |
2023―Dec―23 |
Addressing Th1/17-associated immune dysfunction in psoriasis patients enhances the effectiveness of the inactivated SARS-CoV-2 vaccine |
Chao Ji, Yihua Zhang, Li Li, Shi-Fan Ruan, Liangqi Cai, Kunli Zhou, Donghua Cai, Yalan Dai, Jianping Lan, Liangliang Zhang, Qiuyun Xu, Ying Zou, Hui Ke, Zhenlan Wu, Zhixun Xiao, Bo Cheng, Ting Gong, Dezhi Kang |
| 9 |
[GO] |
2023―Dec―18 |
Attitudes towards clinical research in adult patients with hidradenitis suppurativa during the COVID-19 pandemic: Insights from a survey |
Nikolaj Holgersen, Valdemar W. Nielsen, Zarqa Ali, Mette Brøgger-Mikkelsen, Marius M. Flege, Jacob P. Thyssen, Alexander Egeberg, Simon F. Thomsen |
| 10 |
[GO] |
2023―Dec―14 |
Secondary livedoid vasculopathy following SARS-CoV-2 infection |
A. M. Carballido Vázquez, T. L. Vega López, P. Manchado López, G. Martínez García, A. Mateos Mayo |
| 11 |
[GO] |
2023―Dec―09 |
Reply to ‘New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination’ |
E. Magnaterra, E. B. Mariotti, A. Corrà, C. Aimo, L. Quintarelli, V. Ruffo di Calabria, A. Verdelli, M. Caproni |
| 12 |
[GO] |
2023―Nov―01 |
Cutaneous Tuberculosis and its possible association with COVID-19 |
Neerja Saraswat, Durga Madhab Tripathy, Abhishek Mishra, Sushil Kumar, Shobhit Goel |
| 13 |
[GO] |
2023―Nov―01 |
Reactive Infectious Mucocutaneous Eruption (RIME) secondary to COVID-19 infection: A Case Report and Review of the literature |
Georgia Koroneos, William Berry, Nicola Sweeney, Vanessa Morgan, Nur-Shirin Harun, Jenny Nicolopoulos |
| 14 |
[GO] |
2023―Oct―05 |
Lichen planus pemphigoides after COVID-19 infection |
D. Didona, A. M. Sequeira-Santos, J. Hinterseher, T. Cunha, M. Hertl |
| 15 |
[GO] |
2023―Sep―15 |
New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination |
E. Hansen, R. Feldmann, R. Pirker, J. Jochmann, F. Breier, C. Posch |
| 16 |
[GO] |
2023―Sep―14 |
The Gabrin Sign's Potential for Identifying High-Risk Patients for COVID-19 with Androgenic Alopecia |
Alpana Mohta, Sumiti Pareek, Vijeta Prasad, Achala Mohta, Asha Nyati |
| 17 |
[GO] |
2023―Aug―23 |
Aquagenic keratoderma as a consequence of excessive handwashing during the COVID-19 pandemic-A case report |
Raquel Falcão de Freitas, António Freitas |
| 18 |
[GO] |
2023―Aug―23 |
Ulcerating reaction in association with Pfizer-BioNTech COVID-19 vaccine in an 11-year-old boy |
Justin Thrush, Samantha Polly, John Anthony, James Fernandez, James Taylor, DeVon C. Preston, Anthony P. Fernandez |
| 19 |
[GO] |
2023―Aug―19 |
A case of COVID-19-associated generalized indeterminate cell histiocytosis successfully treated with systemic PUVA |
Finn Abeck, Justus Vehring, Domenica Varwig-Janßen, Anne Menz, Maria Christolouka, Stefan W. Schneider |
| 20 |
[GO] |
2023―Aug―10 |
A case of generalized pustular psoriasis complicated by acute respiratory distress syndrome after COVID-19 vaccination |
Ayaka Itami, Tomomitsu Miyagaki, Shuhei Mitsuishi, Akihiro Horie, Tatsuro Okano, Sora Takeuchi, Takayasu Ando, Takafumi Kadono |
| 21 |
[GO] |
2023―Aug―10 |
A severe relapse of Pemphigus Vulgaris after SARS-CoV-2 vaccination. |
L. Ligrone, S. Lembo, F. Cillo, S. Spennato, G. Fabbrocini, A. Raimondo |
| 22 |
[GO] |
2023―Jul―20 |
Bullous pemphigoid with autoantibodies against full-length BP180 protein after COVID-19 infection |
Kazumasa Oya, Masakazu Kakurai, Kentaro Izumi, Norito Ishii, Toshifumi Nomura |
| 23 |
[GO] |
2023―Jul―17 |
Gianotti-Crosti syndrome following Covid-19 infection |
M. Ben Kahla, J. Rouatbi, N. Ghariani Fetoui, A. Aounallah, B. Sriha, C. Belajouza, N. Ghariani, S. Mokni, M. Lahouel, M. Denguezli |
| 24 |
[GO] |
2023―Jul―07 |
Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS-CoV-2 vaccine - a case review |
K. Kanabaj, M. Sokołowska-Wojdyło, A. Wilkowska, R. J. Nowicki |
| 25 |
[GO] |
2023―Jun―28 |
Papuloerythroderma of Ofuji following COVID-19 vaccination |
Yu-Wen Huang, Wen-Hung Chung, Chun-Bing Chen |
| 26 |
[GO] |
2023―Jun―20 |
A case of recurrence of pyoderma gangrenosum after Covid-19 vaccine |
L. Bettolini, S. Bighetti, S. Mezzana, A. Gelmetti, P. Calzavara-Pinton, V. Maione |
| 27 |
[GO] |
2023―Jun―17 |
New-onset pemphigus vulgaris and pemphigus foliaceus following COVID-19 infection and vaccination, systematic review of case reports and a causal hypothesis |
S. Petti, P. G. Arduino |
| 28 |
[GO] |
2023―Jun―16 |
Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection |
S. Skrek, V. Di Lernia, A. Beauchet, A.-C. Bursztejn, A. Belloni Fortina, A. Lesiak, J. Thomas, P. Brzezinski, Z. Topkarci, N. Murashkin, T. Torres, R. Epishev, A. Chiriac, T. McPherson, M. Akinde, A. Maruani, P. C. Luna, H. Vidaurri de la Cruz, S. Mallet, S. Leducq, M. Sergeant, J. Zitouni, S. K. Mahil, C. H. Smith, C. Flohr, H. Bachelez, E. Mahé |
| 29 |
[GO] |
2023―Jun―16 |
Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination” by Gambichler. |
Luca Potestio, Fabrizio Martora, Alessia Villani, Matteo Megna, Angelo Ruggiero |
| 30 |
[GO] |
2023―Jun―09 |
Impact of COVID-19 in patients with autoimmune bullous diseases: report from an international registry |
Joost M. Meijer, Hanan Rashid, Styliani Vergadi, Emiliano Antiga, Pamela Vezzoli, Riccardo Balestri, Aikaterini Patsatsi, Soner Uzun, Dusan Skiljevic, Hana Jedlickova, Lucia Janickova, Alberto Corrà, Alessandra Ponziani, Claudia Günther, Giuseppe Cianchini, Matthias Schefzyk, Angelo Marzano, Giovanni Di Zenzo, Iakov Shimanovich, Janet Fairley, Jose M. Mascaró Jr, Marzia Caproni, Roberto Maglie, Enno Schmidt, Barbara Horváth |
| 31 |
[GO] |
2023―May―17 |
A case of Covid-19-related vulval ulceration coupled with genital viral shedding |
E. Mastoraki, S. Niforatou-Daskalaki, C. B. Bunker, G. Kravvas |
| 32 |
[GO] |
2023―May―12 |
Corrigendum: Impact of
SARS-CoV
-2 infection in children with psoriasis: Results of a monocentric experience |
|
| 33 |
[GO] |
2023―Apr―28 |
SARS-CoV-2 vaccination may trigger and exacerbate mucosal lichen planus |
A. Dangien, D. Darbord, J. Chanal, J. Wendling, C. Pantoja, B. Oules, C. Lheure, E. Ouedraogo, N. Kramkimel, M. Barret, F. Beuvon, F. Plantier, S. Guegan, S. Aractingi, V. Seta, P. Sohier, C. Isnard, N. Dupin |
| 34 |
[GO] |
2023―Apr―28 |
Exacerbation of Acquired Perforating Dermatosis Following SARS-CoV-2 Vaccination |
Nadia Sciamarrelli, Niccolò Siliquini, Luca Mastorino, Rebecca Senetta, Paolo Dapavo, Simone Ribero, Pietro Quaglino |
| 35 |
[GO] |
2023―Apr―27 |
SARS-CoV
-2 infection associated with severe oral, conjunctival and genital lesions (Fuchs syndrome) |
N. Ganjuur, D. F. D’Urso, G. M. Girbig, N. Booken, M. Augustin |
| 36 |
[GO] |
2023―Apr―15 |
Acute generalized exanthematous pustulosis (AGEP) in a patient with COVID-19 infection |
L. De Brucker, L. Seyler, G. Leemans, J. Gutermuth, M. Grosber |
| 37 |
[GO] |
2023―Apr―05 |
VEXAS syndrome following COVID-19 mRNA vaccination |
François Skowron, Lucas Klepfisch, Laurent Guillaume, Janique Godeneche, Anthony Facile, Martin Gombert, Suzann Pechuzal, Jean-Luc Perrot |
| 38 |
[GO] |
2023―Apr―05 |
Leprosy reactions after SARS-COV2 (COVID-19) infection |
I. M. Gutiérrez-Villarreal, J. Ocampo-Candiani, A. Villarreal-Martinez, M. Gomez-Flores, L. T. Fernández, G. Rodríguez-Tamez, D. M. Pérez-Garza, G. González-Martínez, L. A. Yamallel-Ortega, S. Chavez-Alvarez |
| 39 |
[GO] |
2023―Apr―05 |
Erythema multiforme major associated with molnupiravir treatment for SARS-CoV-2 infection: first report |
Corrado Zengarini, Vito Epifani, Carlotta Baraldi, Martina Mussi, Luciano Potena, Laura Giovannini, Alessandro Pileri |
| 40 |
[GO] |
2023―Apr―05 |
Delay in the diagnosis and management of suspicious malignant skin lesions during the
COVID
-19 pandemic in a reference center in Mexico |
Eduardo Corona-Rodarte, Antonio Olivas-Martinez, Rodrigo Solis-Pompa, Luis Enrique Cano-Aguilar, Daniel Asz-Sigall, María del Rocío Ferrusco-Ontiveros, José Alfredo Soto-Ortiz, Liliana Burgos-Mora |
| 41 |
[GO] |
2023―Mar―14 |
SARS-CoV
-2 vaccination status and adverse events among patients with psoriasis - data from the German Registries
PsoBest
and
CoronaBest |
M. Valencia López, A. Meineke, B. Stephan, S. Rustenbach, A. Kis, D. Thaci, U. Mrowietz, K. Reich, P. Staubach-Renz, R. von Kiedrowski, H. Bogena, M. Augustin |
| 42 |
[GO] |
2023―Mar―14 |
Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination |
Thilo Gambichler |
| 43 |
[GO] |
2023―Mar―13 |
Sweet Syndrome following
SARS-CoV
-2 infection: a unique bullous photo-distributed presentation |
Cláudia Brazão, Dora Mancha, Luís Soares-de-Almeida, Paulo Filipe |
| 44 |
[GO] |
2023―Mar―13 |
Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIV |
A. Simsek, C. Bessen, T. L. Meister, D. Urlaub, A. Skaletz-Rorowski, N. H. Brockmeyer, O. Overheu, A. Reinacher-Schick, S. Faissner, C. Watzl, S. Pfaender, I. Schmitz, A. Potthoff, C. Plaza-Sirvent |
| 45 |
[GO] |
2023―Mar―08 |
Telogen Effluvium in
SARS-CoV
-2 Infection: histological aspects |
S. Michelini, G. Caro, M. Di Fraia, M. Fortuna, F. Magri, V. V. Gomes, T. Grieco, M. Carlesimo, A. Rossi, G. Pellacani |
| 46 |
[GO] |
2023―Feb―25 |
Impact of
COVID
-19 pandemic on acute Dermatology referrals in a secondary and tertiary care Central London Hospital. A retrospective comparison review of
pre-COVID
-19 era and
COVID
-19 pandemic |
E. Panagou, E. Panou, J. Crawley, O. Veraitch, E. V. Edmonds, C. B. Bunker, C. L. Martyn-Simmons |
| 47 |
[GO] |
2023―Feb―18 |
Excess Psoriasis and Psoriatic Arthritis Mortality During the
COVID
-19 Pandemic in the United States: A Nationwide
Population-Based
Study from 2010-2021 |
Ying Liu, Xinyuan He, Ernest Y. Lee, Fan Lv, Leiqing Yao, Qinqin Meng, Lan Zhang, Wee Han Ng, Yanfei Zhang, Peter M. Elias, Maoqiang Man, Yee Hui Yeo, Zhengxiao Li |
| 48 |
[GO] |
2023―Feb―14 |
Covid-19-associated chilblain pruritus is non-histaminergic mediated and correlated to epidermal interleukin 31 |
Angelina Labib, Leigh Nattkemper, Ashley Vander Does, Teresa Ju, Sara Cacciapuoti, Maria Vastarella, Gabriella Fabbrocini, Gil Yosipovitch |
| 49 |
[GO] |
2023―Feb―14 |
Clinical and immunological impact of booster immunization with recombinant
mRNA
vaccines for
SARS-CoV
-2 in patients with pemphigus and bullous pemphigoid |
F. Solimani, A. Mesas-Fernandez, E. Bodner, M. Carevic-Neri, M. Hasheminasab, T. Jakovljevicova, A. Philipp, A. Nast, M. Worm, F. J. Hilke, K. Meier, K. Ghoreschi |
| 50 |
[GO] |
2023―Feb―14 |
The impact of the
COVID
-19 pandemic on the diagnosis of cutaneous melanomas; a retrospective cohort study from five European skin cancer reference centers |
Alexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko, Phil F. Cheng, Mitchell L. Levesque, Eva Hadaschik, Elisabeth Livingstone, Ketty Peris, Lukas Flatz, Peter Koelblinger, Reinhard Dummer, Florentia Dimitriou |
| 51 |
[GO] |
2023―Feb―03 |
Heterologous
Vs
homologous primary and booster COVID-19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: insights from a real-life, multicenter, case-control study |
Santo Raffaele Mercuri, Alessia Pacifico, Piergiorgio Malagoli, Vittoria Giulia Bianchi, Fabrizio Ernesto Pregliasco, Massimo Del Fabbro, Giovanni Damiani |
| 52 |
[GO] |
2023―Jan―22 |
Reply to: ‘Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab’ by Baffa
et al |
L. Sun, C. Brazão, D. Mancha, L. Soares-de-Almeida, P. Filipe |
| 53 |
[GO] |
2023―Jan―20 |
Risk-benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: a prospective cohort study |
C. Seree-aphinan, P. Suchonwanit, P. Rattanakaemakorn, C. Pomsoong, Y. Ratanapokasatit, C. Setthaudom, T. Suangtamai, K. Chanprapaph |
| 54 |
[GO] |
2023―Jan―20 |
Study of covid-19 vaccine related cutaneous adverse events following immunization and establishing causal association |
Rohini Sharma |
| 55 |
[GO] |
2023―Jan―17 |
Impact of SARS-CoV-2 infection in children with psoriasis: results of a monocentric experience |
Francesca Caroppo, Laura Fagotto, Jacopo Tartaglia, Roberto Mazzetto, Anna Belloni Fortina |
| 56 |
[GO] |
2023―Jan―16 |
Dupilumab treatment for severe atopic dermatitis in children and
SARS-CoV2
infection: a combination of triggers for psoriasis |
C. Colonna, P. Bortoluzzi, R. Cavalli |
| 57 |
[GO] |
2023―Jan―06 |
Epidermal necrolysis after COVID-19 vaccination: An exploratory analysis using World Health Organization
VigiBase |
B. Ahouach, E. Diaz, B. Bertin, B. Ben Said, S. Combret, A. Grandvuillemin, N. Petitpain, M. B. Rabier, L. Thomas, T. Trenque, S. Ingen-Housz-Oro, B. Lebrun-Vignes |
| 58 |
[GO] |
2023―Jan―06 |
Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy |
J.-M. Placke, D. Mertens, A. Tasdogan, E. Chorti, D. Schadendorf, S. Ugurel, A. Roesch, I. Stoffels, J. Klode |
| 59 |
[GO] |
2022―Dec―14 |
New insights on acral peeling dermatoses: an overlooked skin manifestation during COVID-19 pandemic |
Iria Neri, Alba Guglielmo, Annalucia Virdi, Miriam Leuzzi, Bianca Maria Piraccini, Marco Adriano Chessa |
| 60 |
[GO] |
2022―Dec―05 |
Real-world data on primary cutaneous lymphoproliferative disorders following
SARS-CoV
-2 vaccination: a multicentre experience from tertiary referral hospitals |
G. Avallone, C. A. Maronese, C. Conforti, P. Fava, L. Gargiulo, A. V. Marzano, C. Massone, L. Mastorino, A. Paradisi, A. Pileri, P. Quaglino, N. Rizzo, S. Ribero, G. Roccuzzo, G. Tavoletti, C. A. Vignoli, I. Zalaudek, E. Berti, S. Alberti-Violetti |
| 61 |
[GO] |
2022―Nov―28 |
Capillaritis as cutaneous adverse reaction to
SARS-CoV
-2 primary and booster vaccination: A series of eight cases |
Luca Di Bartolomeo, Federico Vaccaro, Francesco Borgia, Maria Lentini, Caterina Longo, Mario Vaccaro |
| 62 |
[GO] |
2022―Nov―22 |
Pityriasis rubra pilaris following inactivated
SARS-CoV
-2 vaccine (
CoronaVac
) |
Li-wen Zhang, Wen-ju Wang, Li-xin Fu, Yong-hong Lu, Tao Chen, Rong-hua Xu |
| 63 |
[GO] |
2022―Nov―17 |
Lichen planus after COVID-19 infection and vaccination: a systematic review |
Betty Nguyen, Alexandra G. Perez, George W. Elgart, Scott A. Elman |
| 64 |
[GO] |
2022―Nov―15 |
COVID-19 vaccine-induced Sweet syndrome presenting as fingertip pustules |
Subhajit Sadhukhan, Sahiba Rafi, Anupama Bains, Divya Aggarwal |
| 65 |
[GO] |
2022―Oct―21 |
A cross-sectional study of dermatologists’ attitudes toward COVID-19 vaccination in patients with immunobullous diseases |
M. Kasperkiewicz, R. Strong, M. Yale, P. Dunn, D. T. Woodley |
| 66 |
[GO] |
2022―Oct―21 |
Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab |
M. E. Baffa, R. Maglie, F. Montefusco, C. Pipitò, S. Senatore, E. Antiga |
| 67 |
[GO] |
2022―Sep―27 |
Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site. |
L. Revenga-Porcel, Y. Peñate, F. Granados-Pacheco |
| 68 |
[GO] |
2022―Sep―23 |
Course and outcome of chilblain-like acral lesions during COVID-19 pandemic |
K. Blau, S. Lehr, R. Aschoff, S. Al Gburi, N. Brück, M. Chapsa, A. Schnabel, S. Abraham, K. Jöhrens, S. Beissert, C. Günther |
| 69 |
[GO] |
2022―Sep―23 |
Regression of common viral warts in an immunocompetent child and an immunosuppressed adult relative after mRNA BNT162b2 COVID-19 vaccine |
Maria Dalamaga, Dimitrios Tsilingiris, Alexandros Katoulis |
| 70 |
[GO] |
2022―Aug―22 |
COVID-19 induced pityriasis rubra pilaris: a superantigenic disease? |
Italo Francesco Aromolo, Armando Pisapia, Davide Riva, Francesco Barberi, Angelo Valerio Marzano, Chiara Moltrasio, Maurizio Romagnuolo |
| 71 |
[GO] |
2022―Aug―22 |
Reply to A. Ruggiero
et Al
. to our article “Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity” |
R. Molinier, A. Roger, B. Genet, P. Saiag, E. Funck-Brentano |
| 72 |
[GO] |
2022―Aug―22 |
The effects of
COVID
-19 pandemic on malignant melanoma diagnosis |
Alessia Villani, Massimiliano Scalvenzi, Gabriella Fabbrocini, Luigi Fornaro, Gianluca Guerrasio, Luca Potestio |
| 73 |
[GO] |
2022―Aug―22 |
Despite the use of ivermectin during the
COVID
pandemic, scabies keeps playing tricks with us |
Juliana Polizel Ocanha Xavier, José Cândido Caldeira Xavier-Jr |
| 74 |
[GO] |
2022―Aug―22 |
Rituximab in immunobullous disorders during the
COVID
-19 pandemic: a systematic review of observational studies |
M. Kasperkiewicz, D. T. Woodley |
| 75 |
[GO] |
2022―Aug―20 |
Authors’ reply to comment by Ciccarese
et al
. regarding “Negative
SARS-CoV
-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions” |
E. Welsh, J. A. Cardenas-de la Garza, E. Brussolo-Marroquín, A. Cuellar-Barboza, R. Franco-Marquez, Gerardo Ramos-Montañez |
| 76 |
[GO] |
2022―Aug―17 |
Comment on “Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions” |
G. Ciccarese, F. Broccolo, A. Parodi, F. Drago |
| 77 |
[GO] |
2022―Aug―16 |
Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic |
M. J. Monroy-Iglesias, H. Hadi, B. Russell, C. Moss, L. Flanders, S. Dolly, S. Papa, M. Van Hemelrijck |
| 78 |
[GO] |
2022―Aug―16 |
Reply to “Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity” by R. Molinier et al. |
Angelo Ruggiero, Fabrizio Martora, Fabrizio Fornaro, Massimiliano Scalvenzi, Gabriella Fabbrocini, Alessia Villani |
| 79 |
[GO] |
2022―Aug―16 |
Skin reaction after Sars-Cov-2 vaccines Reply to ‘Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience’ |
Fabrizio Martora, Alessia Villani, Claudio Marasca, Gabriella Fabbrocini, Luca Potestio |
| 80 |
[GO] |
2022―Aug―14 |
Authors’ reply to: “Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine” |
M. Bertello, G. Rubegni, P. Rubegni, L. Tognetti |
| 81 |
[GO] |
2022―Aug―14 |
New onset pemphigus foliaceus following AstraZeneca COVID-19 vaccination |
M. Almasi-Nasrabadi, R. S. Ayyalaraju, A. Sharma, S. Elsheikh, S. Ayob |
| 82 |
[GO] |
2022―Aug―14 |
Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation |
M. Kasperkiewicz, R. Strong, M. Yale, P. Dunn, D. T. Woodley |
| 83 |
[GO] |
2022―Aug―14 |
Association of Interstitial Granulomatous Dermatitis with Messenger Rna-1273 Sars-Cov-2 Vaccine |
C. Ariasi, G. Perazzolli, A. Gelmetti, S. Battocchio, P. G. Calzavara-Pinton |
| 84 |
[GO] |
2022―Aug―11 |
Alopecia areata after COVID-19 infection and vaccination: a cross-sectional analysis |
Betty Nguyen, Antonella Tosti |
| 85 |
[GO] |
2022―Jul―16 |
Pityriasis lichenoides chronica after
BNT162B2 Pfizer-BioNTech
vaccine: A novel cutaneous reaction after
SARS-CoV
-2 vaccine |
F Drago, G Ciccarese, A Guadagno, A Parodi |
| 86 |
[GO] |
2022―Jul―05 |
Reply to “Development of severe pemphigus vulgaris following
SARS-CoV
-2 vaccination with
BNT162b2
” by Solimani F et al. |
Francesca Falcinelli, Arianna Lamberti, Carlo Cota, Pietro Rubegni, Elisa Cinotti |
| 87 |
[GO] |
2022―Jun―30 |
Influence of Covid-19 vaccination on immune-mediated skin diseases |
Narjes A Alelq, Michaela E Kubieniec, Lars E French, Jörg C Prinz |
| 88 |
[GO] |
2022―Jun―30 |
Pyoderma gangrenosum after
mRNA
-based
SARS-CoV
-2 vaccine |
J. Franceschi, AS. Darrigade, P. Sanchez-Pena, V. Legrain-Lifermann, B. Milpied |
| 89 |
[GO] |
2022―Jun―30 |
Cutaneous adverse reaction following
SARS-CoV
-2 vaccine booster dose: a real-life multicentre experience |
G Avallone, F Cavallo, C Astrua, G Caldarola, C Conforti, C De Simone, N di Meo, A di Stefani, G Genovese, CA Maronese, AV Marzano, R Parente, P Quaglino, G Roccuzzo, F Tassone, I Zalaudek, R Senetta, S Ribero |
| 90 |
[GO] |
2022―Jun―29 |
A spectrum of leprosy reactions triggered by Covid-19 vaccination: a series of four cases |
N. Saraswat, D. M. Tripathy, S. Kumar, P. Awasthi, M. M. Gopal |
| 91 |
[GO] |
2022―Jun―24 |
Types and Prevalence of Adverse Skin Reactions Associated With Prolonged
N95
and Simple Mask Usage during the
COVID
-19 Pandemic |
Ariel R. Darnall, Dana Sall, Curt Bay |
| 92 |
[GO] |
2022―Jun―20 |
Long-term effects of the COVID-19 pandemic on malignant melanoma: increased lymph node metastases in two German dermatology clinics |
Galina Balakirski, Alena-Lioba Michalowitz, Alexander Kreuter, Silke C. Hofmann |
| 93 |
[GO] |
2022―Jun―20 |
Ultrastructural evidence for anagen hair follicle infection with
SARS-CoV
-2 in early-onset
COVID
-19 effluvium |
I.F.S. Mazeto, C.C. Brommonschenkel, A.C. Miola, P. Müller Ramos, D. Carvalho dos Santos, H.A. Miot |
| 94 |
[GO] |
2022―Jun―20 |
Sweet Syndrome following SARS-CoV-2 CoronaVac vaccine |
Nesrine Ben Salah, Mouna Korbi, Najeh Ben Fadhel, Idoudi Safa, Ferdaous Chad, Manel Njima, Hichem Belhadjali, Montassar Amri, Karim Aouem, Jameleddine Zili |
| 95 |
[GO] |
2022―Jun―20 |
Maternal SARS-CoV-2 infection and aplasia cutis congenita in a newborn |
Yan Jiang, Xue Yu, Ming-Gang Deng, Chun-Xiang Wu, Xiao-Yu Xu, Ting Luo, Zhi-Jiang Zhang |
| 96 |
[GO] |
2022―Jun―17 |
From COVID-19 to war - life of a dermatological journal in times of crisis |
J. Ring |
| 97 |
[GO] |
2022―Jun―10 |
Erythema nodosum following
SARS-CoV
-2 vaccine |
Yihang Xie, Bin Yin, Xin Shi |
| 98 |
[GO] |
2022―Jun―10 |
Hansen's disease case detection in Brazil: a backlog of undiagnosed cases due to
COVID
-19 pandemic |
P. Deps, S. M. Collin, V. L. Gomes de Andrade |
| 99 |
[GO] |
2022―Jun―10 |
New onset of sarcoidosis after COVID-19 infection |
Andrea Rabufetti, Luca Borradori, Kristine Heidemeyer, Laurence Feldmeyer, Robert E. Hunger, Nikhil Yawalkar, S. Morteza Seyed Jafari |
| 100 |
[GO] |
2022―Jun―09 |
Reply to ‘Development of severe pemphigus vulgaris following
SARS-CoV
-2 vaccination with
BNT162b2
’ by Solimani
et al |
M. Fabrizio, F. Gabriella, P. Nappa, M. Matteo |
| 101 |
[GO] |
2022―Jun―06 |
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis |
C. Washrawirul, J. Triwatcharikorn, J. Phannajit, M. Ullman, P. Susantitaphong, P. Rerknimitr |
| 102 |
[GO] |
2022―May―26 |
A case of pityriasis lichenoides et varioliformis acuta (PLEVA) developed after first dose of Oxford-AstraZeneca COVID-19 vaccine |
Federica Filippi, Carlotta Baraldi, Pier Luigi Zinzani, Beatrice Casadei, Alessandro Pileri |
| 103 |
[GO] |
2022―May―23 |
Efficacy of low-dose methotrexate in a short-regimen for granulomatous sarcoid-like reaction on permanent make-up during COVID-19 infection |
Nicolas Kluger, Vincent Descamps |
| 104 |
[GO] |
2022―May―23 |
Maskne prevalence and risk factors during the COVID-19 pandemic |
Alessia Villani, Gabriella Fabbrocini, Maria Carmela Annunziata, Luca Potestio |
| 105 |
[GO] |
2022―May―23 |
Nail psoriasis: a rare mRNA COVID-19 vaccine reaction |
A. Lamberti, V. Lora, D. Graceffa, C. Bonifati, C. Cota |
| 106 |
[GO] |
2022―May―23 |
Generalized morphea after COVID-19 vaccines: a case series |
G Paolino, C Campochiaro, MR Di Nicola, SR Mercuri, N Rizzo, L Dagna, F Rongioletti, G De Luca |
| 107 |
[GO] |
2022―May―23 |
Urticarial vasculitis triggered by SARS-CoV-2 vaccine (mRNA vaccine) |
M Daldoul, M Korbi, A Bellalah, N Ben Fadhel, H Belhadjali, J Zili |
| 108 |
[GO] |
2022―May―16 |
Impact of the Covid-19 pandemic on Melanoma and Non-melanoma skin cancer inpatient treatment in Germany - a nationwide analysis |
Johannes Kleemann, Markus Meissner, Deniz Özistanbullu, Ümniye Balaban, Oliver Old, Stefan Kippenberger, Jan Kloka, Roland Kaufmann, Kai Zacharowski, Benjamin Friedrichson |
| 109 |
[GO] |
2022―May―11 |
Effects of wearing personal protective equipment during COVID-19 pandemic on composition and diversity of skin bacteria and fungi of medical workers |
X. Lin, Y.Z. Li, T. Chen, S.H. Min, D.F. Wang, M.M. Ding, G. Jiang |
| 110 |
[GO] |
2022―May―10 |
Erythrodermic pityriasis rubra pilaris after SASRS-CoV-2 vaccination with concomitant COVID-19 infection |
T. Gambichler, C.H. Scheel, Y. Arafat, O. Kautz, S. Boms |
| 111 |
[GO] |
2022―May―10 |
A case of onychomadesis associated to chilblain-like lesions after COVID-19 infection |
Cristiana Colonna, Serena Giacalone, Martina Zussino, Nicola Adriano Monzani, Stefano Cambiaghi, Riccardo Cavalli |
| 112 |
[GO] |
2022―May―10 |
Reactive infectious mucocutaneous eruption triggered by COVID-19 infection in an adult patient |
Elena Gimeno, Daniel Morgado-Carrasco, David Moriscot, Jaime Piquero-Casals |
| 113 |
[GO] |
2022―May―10 |
Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event |
Michael Kasperkiewicz |
| 114 |
[GO] |
2022―May―10 |
Development of delayed dermal hypersensitivity reaction following the second dose of COVID-19 vaccine- a series of 37 cases |
Alpana Mohta, Manoj Kumar Sharma |
| 115 |
[GO] |
2022―May―10 |
Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination |
Alexander Kreuter, Sara Lausch, Sven-Niklas Burmann, Alexandros Paschos, Alena-Lioba Michalowitz |
| 116 |
[GO] |
2022―May―10 |
Allergic reaction to Red Cosmetic lip tattoo with possible exacerbations after SARS-CoV-2 vaccination |
Nicolas Kluger |
| 117 |
[GO] |
2022―Apr―26 |
Role of the International Pemphigus and Pemphigoid Foundation during the COVID-19 pandemic |
M. Kasperkiewicz, R. Strong, M. Yale, P. Dunn, D. T. Woodley |
| 118 |
[GO] |
2022―Apr―26 |
Negative
SARS-CoV
-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions |
E. Welsh, J. A. Cardenas-de la Garza, E. Brussolo-Marroquín, A. Cuellar-Barboza, R. Franco-Marquez, Gerardo Ramos-Montañez |
| 119 |
[GO] |
2022―Apr―16 |
Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire based study |
Jai Bawane, Rajesh Kataria, Anil Mohite, Kapila Verma, Utkarsh Shukla |
| 120 |
[GO] |
2022―Apr―16 |
Disseminated herpes zoster in an immune-competent patient after
SARS-CoV
-2 Vaccine (
BNT162b2
Comirnaty, Pfizer) |
Corrado Zengarini, Cosimo Misciali, Tiziano Ferrari, Emi Dika, Michelangelo La Placa, Bianca Maria Piraccini, Carlotta Baraldi |
| 121 |
[GO] |
2022―Apr―16 |
SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruption |
Dillon Mintoff, David Pisani, Nevise Livori, Ian Said-Huntingford, Godfrey Baldacchino |
| 122 |
[GO] |
2022―Apr―10 |
Hemorrhagic bullous pyoderma gangrenosum following COVID-19 vaccination |
Yi-Teng Hung, Wen-Hung Chung, Tsung-Fu Tsai, Chun-Bing Chen |
| 123 |
[GO] |
2022―Mar―30 |
Commentary on “Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine” |
Dursun Turkmen, Nihal Altunisik |
| 124 |
[GO] |
2022―Mar―30 |
Autoimmune bullous dermatoses associated with COVID-19 outbreak in Russian patients: a single case series |
A. Lepekhova, E. Grekova, O. Olisova, E. Dunaeva, S. Ahmed, I. Maximov, N. Teplyuk |
| 125 |
[GO] |
2022―Mar―30 |
A rare case of reactive granulomatous dermatitis during COVID-19: a possible role of cephalosporine and potential mechanisms |
A. Aoki, M. Yamane, Y. Aoyama |
| 126 |
[GO] |
2022―Mar―29 |
De novo
annular pustular psoriasis following mRNA COVID-19 vaccine |
M. Romagnuolo, P. Pontini, S. Muratori, A. V. Marzano, C. Moltrasio |
| 127 |
[GO] |
2022―Mar―28 |
Symmetrical drug-related intertriginous and flexural exanthema like eruption after COVID-19 vaccine |
Ines Lahouel, Nesrine Ben Salah, Najeh Ben Fadhel, Ferdaous Chahed, Nourelimene Ouni, Hichem Belhadjali, Karim Aouem, Jameleddine Zili |
| 128 |
[GO] |
2022―Mar―19 |
Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthem |
Andrea Sechi, Andrea Bassi, Carlo Mazzatenta, Mario Cutrone, Luigi Naldi, Giuseppe Argenziano, Vincenzo Piccolo |
| 129 |
[GO] |
2022―Mar―19 |
Transient inflammation in surgical scars following Covid-19 mRNA vaccination |
C. Ferreli, J. Anedda, L. Atzori L |
| 130 |
[GO] |
2022―Mar―12 |
Maskne prevalence and associated factors in Irish healthcare workers during the COVID-19 pandemic |
L.F. Kiely, C. O'Connor, G. O’Briain, C. O’Briain, J. Gallagher, J.F. Bourke |
| 131 |
[GO] |
2022―Mar―12 |
Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin |
P.R. Criado, M. Ianhez, P.S. Rocha, H.A. Miot |
| 132 |
[GO] |
2022―Mar―12 |
Case of lichen planus pigmentosus-inversus after Oxford-AstraZeneca COVID-19 vaccine: cause or coincidence? |
L. Sun, S. Duarte, L. Soares-de-Almeida |
| 133 |
[GO] |
2022―Mar―12 |
Primary cutaneous lymphoma and risk for severe COVID-19: a prospective study of 48 cases in Morocco |
H. Kerrouch, M. Khalidi, R. Frikh, N. Hjira, M. Boui |
| 134 |
[GO] |
2022―Mar―12 |
Healthcare and safety of patients with melanoma during the COVID-19 Pandemic in Italy |
S. Caini, M. Brusasco, G. Niero, V. De Giorgi, M. Lombardo, C. Massone, M. Medri, G. Palmieri, M.A. Pizzichetta, P. Quaglino, R. Satta, C. Feliciani, S. Gandini, I. Stanganelli |
| 135 |
[GO] |
2022―Mar―11 |
Erythema Multiforme in COVID-19 Patients and Following COVID-19 Vaccination: Manifestations, Associations, and Outcomes |
Farshid Etaee, Mohamadmehdi Eftekharian, Tarek Naguib, Steven Daveluy |
| 136 |
[GO] |
2022―Mar―11 |
Prevalence and patterns of cutaneous manifestations in 1,245 COVID-19 patients in Japan: a single-centre study |
T. Sugai, Y. Fujita, E. Inamura, Y. Maya, S. Shimizu |
| 137 |
[GO] |
2022―Mar―11 |
Another case of generalized bullous fixed drug eruption following an adenoviral-vector based Covid-19 vaccine (ChAdOx1 nCov-19) |
Chaker Ben Salem, Abdelmajid Khelif, Dhouha Sahnoun, Nadia Ghariani, Badreddine Sriha, Mohamed Denguezli |
| 138 |
[GO] |
2022―Mar―11 |
Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination |
A Yoshida, T Ikegami, K Igawa |
| 139 |
[GO] |
2022―Feb―28 |
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab |
G. Pavia, L. Gargiulo, F. Spinelli, J. Avagliano, M. Valenti, R. G. Borroni, A. Costanzo, A. Narcisi |
| 140 |
[GO] |
2022―Feb―28 |
Erythema Nodosum Leprosum Post-COVID-19 Vaccination: Endemic while Pandemic |
Tahel Fachler, Karen Olshtain-Pops, Liran Horev |
| 141 |
[GO] |
2022―Feb―27 |
Association between vaccination and immunobullous disorders: A brief, updated systematic review with focus on COVID-19 |
Michael Kasperkiewicz, David T. Woodley |
| 142 |
[GO] |
2022―Feb―20 |
Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination |
Tuomas Mäkilä, Leila Jeskanen, Mariia Butina, Liisa Harjama, Annamari Ranki, Tarja Mälkönen, Nicolas Kluger |
| 143 |
[GO] |
2022―Feb―17 |
A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine |
Shin-ichiro Ohmura, Shiho Hanai, Ryuhei Ishihara, Yusuke Ohkubo, Toshiaki Miyamoto |
| 144 |
[GO] |
2022―Feb―17 |
Reply to “Dermatoses caused by face mask wearing during the COVID-19 pandemic” |
Federico Bardazzi, Lidia Sacchelli, Camilla Loi, Federica Filippi, Alba Guglielmo |
| 145 |
[GO] |
2022―Feb―17 |
Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia |
Yi-Teng Hung, Yen-Lin Huang, Yao-Yu Chang, Wei-Ti Chen |
| 146 |
[GO] |
2022―Feb―08 |
Stevens-Johnson Syndrome induced by Vaxvetria (AZD1222) Covid-19 vaccine |
C. Aimo, E.B. Mariotti, A. Corrà, E. Cipollini, O. Le Rose, C. Serravalle, N. Pimpinelli, M. Caproni |
| 147 |
[GO] |
2022―Jan―29 |
The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: trends in diagnoses and magnitude of diagnostic delays |
E. Slotman, K. Schreuder, T.E.C. Nijsten, M. Wakkee, L. Hollestein, A. Mooyaart, S. Siesling, M.W.J. Louwman |
| 148 |
[GO] |
2022―Jan―26 |
Estimating the incidence of Covid-19 skin manifestations on the general population in a territorial setting |
Corrado Zengarini, Alba Guglielmo, Matteo Giovani, Cecilia Preci, Emi Dika, Bianca Maria Piraccini, Alessandro Pileri |
| 149 |
[GO] |
2022―Jan―25 |
Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre |
Dimitra Koumaki, Sabine-Elke Krueger-Krasagakis, Marios Papadakis, Alexander C. Katoulis, Ioanna Gkiaouraki, Kyriaki Zografaki, Dimitris Mylonakis, Konstantinos Krasagakis |
| 150 |
[GO] |
2022―Jan―24 |
Eruptive pyogenic granulomas following COVID-19. |
Carlo Alberto Maronese, Chiara Moltrasio, Dario Antonio Marletta, Giovanni Genovese, Angelo Valerio Marzano |
| 151 |
[GO] |
2022―Jan―24 |
Atopic Dermatitis exacerbation after Covid-19 vaccination in Dupilumab treated patients |
L. Potestio, M. Napolitano, L. Bennardo, G. Fabbrocini, C. Patruno |
| 152 |
[GO] |
2022―Jan―24 |
A study of COVID-19 vaccine (Covishield) induced dermatological adverse effects from India |
S Arora, G K Singh, P Das, R Rahman, P Bellad, R Shrivastav, Amit Bahuguna, Devyani Sapra, Akanksha Gupta |
| 153 |
[GO] |
2022―Jan―24 |
Reply to “The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?” by Damiani G et al. |
G Avallone, S Giordano, C Astrua, M Merli, R Senetta, C Conforti, S Ribero, AV Marzano, P Quaglino |
| 154 |
[GO] |
2022―Jan―24 |
Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination |
W.-K. Hung, C.-C. Chi |
| 155 |
[GO] |
2022―Jan―23 |
Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccination |
T. Ogawa, U. Aitake, T. Nomura |
| 156 |
[GO] |
2022―Jan―23 |
A first case of “Covid toes” from a viral vector-based COVID-19 vaccine |
A. Van Loon, D. Mortelmans, V. Siozopoulou, B. Ogunjimi, H. Jansens, J. Lambert, O. Aerts |
| 157 |
[GO] |
2022―Jan―16 |
Skin adverse reactions to Sars-CoV-2 vaccination: a relevant responsibility issue for dermatologists |
P. Gisondi, F. Bellinato, G. Girolomoni |
| 158 |
[GO] |
2022―Jan―12 |
Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccine |
Jerome Kaikati, Antoine Ghanem, Reem El Bahtimi, Josiane Helou, Roland Tomb |
| 159 |
[GO] |
2022―Jan―11 |
Clinical improvement of atopic dermatitis in two patients co-affected with non-severe COVID-19 infection: A case series and review of literature |
Gaetano Licata, Dario Buononato, Carmine Fiorentino, Giulia Calabrese, Alina De Rosa, Giuseppe Argenziano, Alessio Gambardella |
| 160 |
[GO] |
2022―Jan―11 |
Pityriasis lichenoides et varioliformis acuta following COVID-19 mRNA vaccination |
J Palmén, M Lepistö, L Talve, N Hieta |
| 161 |
[GO] |
2022―Jan―11 |
Wells’ syndrome following Oxford-AstraZeneca COVID-19 vaccination |
Yulhee Kim, You Chan Kim |
| 162 |
[GO] |
2022―Jan―11 |
Trigger of Type 2 Lepra reaction with acute foot drop following Covid-19 vaccination |
Anil Kumar Panda, Farheen Begum, Maitreyee Panda, Ajaya Kumar Jena |
| 163 |
[GO] |
2021―Dec―22 |
Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19) |
Clémence Masseran, Andreea Cӑlugӑreanu, Frédéric Caux, Gérôme Bohelay |
| 164 |
[GO] |
2021―Dec―21 |
Telemedicine and Dermatology Hospital Consultations During The COVID-19 Pandemic: A Multi-Center Observational Study on Resource Utilization and Conversion to In-Person Consultations During the COVID-19 Pandemic |
John Trinidad, Colleen K Gabel, Lauren Bonomo, Alexander Cartron, Sidharth Chand, William Coburn, Steven Daveluy, Mark Davis, Katherine L DeNiro, Lauren M Guggina, Jane J Han, Kerry Hennessy, Melissa Hoffman, Kimberly Katz, Jesse J Keller, Soo Jung Kim, Sasank Konda, Eden Lake, Flossy N Lincoln, Jennifer A Lo, Alina Markova, Elizabeth K Marvin, Robert G Micheletti, Sabrina Newman, FNU Nutan, Cuong V Nguyen, Vartan Pahalyants, Jay Patel, Sahand Rahnama-Moghadam, Pranita V Rambhatla, Maureen Riegert, Rachel E Reingold, Danielle B Robinson, Renajd Rrapi, Julio C Sartori-Valinotti, Lucia Seminario-Vidal, Zakariyah Sharif-Sidi, Jan Smogorzewski, Natalie Spaccarelli, Jacob R Stewart, Scott D Tuttle, Marisa N Ulrich, Karolyn A Wanat, Fan Di Xia, Benjamin Kaffenberger, Daniela Kroshinsky |
| 165 |
[GO] |
2021―Dec―20 |
Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review |
Michele Pauluzzi, Giuseppe Stinco, Enzo Errichetti |
| 166 |
[GO] |
2021―Dec―20 |
SCLE manifestation after mRNA COVID-19 vaccination |
Laura Rechtien, Cornelia Erfurt-Berge, Michael Sticherling |
| 167 |
[GO] |
2021―Dec―20 |
Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohort |
E. Massip, P. Marcant, G. Font, S. Faiz, S. Duvert-Lehembre, I. Alcaraz, A. Vermersch-Langlin, M. Véron, C. Macaire, K. Faure, F. Vuotto, D. Staumont-Sallé, F. Dezoteux |
| 168 |
[GO] |
2021―Dec―20 |
High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with SARS-CoV-2 infection. |
Baptiste Mille, Saskia Ingen-Housz-Oro, Nicolas De Prost, Guillaume Voiriot, Angèle Soria, Florence Tetart, Claire Bernier, Cécile Morice, Delphine Staumont-Salle, Frédéric Dezoteux |
| 169 |
[GO] |
2021―Dec―20 |
Primitive melanoma and COVID 19 are we still paying the price of the pandemic? |
F. Ricci, G. Di Lella, L. Fania, F. Ricci, L. Sobrino, S. Pallotta, A. Panebianco, C. Fortes, D. Abeni |
| 170 |
[GO] |
2021―Dec―16 |
Exuberant lichenoid eruption after Oxford-AstraZeneca COVID-19 vaccine: a singular case |
C. Correia, S. Fernandes, L. Soares-de-Almeida, P. Filipe |
| 171 |
[GO] |
2021―Dec―12 |
Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiae |
Alin Laurentiu Tatu, Thomas Nadasdy, LC Nwabudike |
| 172 |
[GO] |
2021―Dec―12 |
Reply to “New-onset cutaneous lichen planus triggered by COVID-19 vaccination” by Merhy et al. |
E Camela, G Guerrasio, C Patruno, M Scalvenzi, N Di Caprio, G Fabbrocini, M Napolitano |
| 173 |
[GO] |
2021―Dec―12 |
Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient |
G Knechtl, SM Seyed Jafari, T Berger, A Rammlmai, L Feldmeye, L Borradori |
| 174 |
[GO] |
2021―Dec―04 |
Trend of sexually transmitted infections during the Covid-19 age. Which was the impact of the pandemic and the social distancing measures? |
L. Ronga, S. Stolfa, F. Romanelli, D.F. Bavaro, A. Saracino, A. Mosca, E. Sparapano, C. De Carlo, M.T. Montagna, G. Diella, L. Nisi, R. Del Prete |
| 175 |
[GO] |
2021―Dec―04 |
Concomitant SARS-CoV-2 infection and crusted scabies in a 4-month infant |
A. Giannattasio, M. Rosa, S. Esposito, O. Di Mita, F. Angrisani, S. Acierno, C. D’Anna, F. Barbato, V. Tipo, O. Ametrano |
| 176 |
[GO] |
2021―Nov―28 |
Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccination |
Ai Kuzumi, Ayumi Yoshizaki, Kazue Chiba, Shunki Mitsuo, Kazuki M Matsuda, Yuta Norimatsu, Kojiro Nagai, Jun Omatsu, Tomomi Miyake, Shinichi Sato |
| 177 |
[GO] |
2021―Nov―28 |
Pityrosporum
folliculitis in critically ill COVID-19 patients |
Fernanda Lagares Xavier Peres, Renan Rangel Bonamigo, Gustavo Borchardt Bottega, Fernanda Luiza Staub, André da Silva Cartell, Bakos Marchiori Renato |
| 178 |
[GO] |
2021―Nov―28 |
Multisystem inflammatory syndrome in adults (MIS-A): a new addition to Covid-19 puzzle |
Kaushiki Hajra, Uddalak Chakraborty, Kingshuk Chatterjee, Atanu Chandra, Saswati Halder |
| 179 |
[GO] |
2021―Nov―22 |
COVID-19 cutaneous manifestations in pediatric patients: 24 MIS-C and 6 Kawasaki disease cases |
A. Tammaro, D. Karim, G. A. R. Adebanjo, F. R. Parisella, C. Chello, A. F. Salih, J. Rello |
| 180 |
[GO] |
2021―Nov―22 |
Lack of association between seborrheic dermatitis and SARS-CoV-2 outcomes |
Uros Rakita, Trisha Kaundinya, Armaan Guraya, Kamaria Nelson, Brittany Maner, Jaya Manjunath, Gabrielle Schwartzman, Brittany Lane, Jonathan I. Silverberg |
| 181 |
[GO] |
2021―Nov―22 |
Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 Vaccine in a patient with primary biliary cholangitis |
Corrado Zengarini, Alessandro Pileri, Francesco Paolo Salamone, Bianca Maria Piraccini, Giovanni Vitale, Michelangelo La Placa |
| 182 |
[GO] |
2021―Nov―13 |
Another year in the grip of COVID-19 with slow recovery |
J. Ring |
| 183 |
[GO] |
2021―Nov―10 |
Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity |
R. Molinier, A. Roger, B. Genet, A. Blom, C. Longvert, L. Chaplain, M. Fort, P. Saiag, E. Funck-Brentano |
| 184 |
[GO] |
2021―Nov―10 |
Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination |
Elisa Cinotti, Jean-Luc Perrot, Francesco Bruzziches, Linda Tognetti, Anastasia Batsikosta, Ester Sorrentino, Angelo Valerio Marzano, Pietro Rubegni |
| 185 |
[GO] |
2021―Nov―10 |
Non-invasive instrumental examinations of cutaneous, adnexal and mucosal manifestations after SARS-COV-2 infection in adult and children |
I. Proietti, E. Tolino, A. Mambrin, N. Skroza, N. Bernardini, A. Marchesiello, F. Marraffa, S. Michelini, G. Rossi, S. Volpe, E. Del Giudice, R. Lubrano, C. Potenza |
| 186 |
[GO] |
2021―Nov―10 |
Dermatologic emergency unit, day-care hospital and consultations in time of COVID-19: the impact of teledermatology |
Alice Brehon, Jason Shourick, Camille Hua, Charbel Skayem, Pierre Wolkenstein, Olivier Chosidow, Tu Anh Duong |
| 187 |
[GO] |
2021―Nov―09 |
At-risk circumstances for COVID-19 increase the risk of pruritus: cross-sectional and longitudinal analyses |
T. Kogame, Y. Ogawa, K. Kabashima, Y. Yamamoto |
| 188 |
[GO] |
2021―Nov―09 |
Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption |
A. Sernicola, A. Dybala, V. Gomes, P. Maddalena, F. Adotti, G. Soda, R. Muharremi, P. Fino, E. Del Duca, T. Grieco |
| 189 |
[GO] |
2021―Oct―26 |
Regression of common viral warts after ChAdOx1-S COVID-19 vaccine |
Anna Płaszczyńska, Martyna Sławińska, Michał Sobjanek |
| 190 |
[GO] |
2021―Oct―20 |
Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine |
N. Cameli, M. Silvestri, M. Mariano, L. Bennardo, S.P. Nisticò, A. Cristaudo |
| 191 |
[GO] |
2021―Oct―19 |
Incidence and Prognosis of COVID-19 in Patients with Psoriasis on Apremilast: A Multicenter Retrospective Cohort Study |
Yuliya Lytvyn, Jorge R Georgakopoulos, Asfandyar Mufti, Alim R. Devani, Melinda J. Gooderham, Vipul Jain, Perla Lansang, Ronald Vender, Vimal H. Prajapati, Jensen Yeung |
| 192 |
[GO] |
2021―Oct―19 |
Comment on “Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases”: could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2? |
Cristina Moya-Martinez, Emilio de Dios Berná-Rico, Ana Melian-Olivera, Carmen Moreno-Garcia del Real, Diego Fernández-Nieto |
| 193 |
[GO] |
2021―Oct―19 |
Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: A prospective cohort study in healthcare workers |
Pawinee Rerknimitr, Thanaporn Puaratanaarunkon, Chanidapa Wongtada, Namthong Wittayabusarakam, Saran Krithin, Leilani Paitoonpong, Chanat Kumtornrut, Stephen J Kerr, Pravit Asawanonda, Watsamon Jantarabenjakul, Jettanong Klaewsongkram |
| 194 |
[GO] |
2021―Oct―19 |
Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine |
C Kouki, K Sellami, E Bahloul, M Amouri, A Masmoudi, H Turki |
| 195 |
[GO] |
2021―Oct―19 |
Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech) |
Minjae Kim, Jee Woo Kim, Minsu Kim, Sun Young Choi, Jung-Im Na |
| 196 |
[GO] |
2021―Oct―19 |
Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma |
Manon Blaise, Fanny Rocher, Hélène Spittler, Adrien Sanchez, Elisabeth Lanteri, Lucia Coco, Angela Puma, Arnaud Martel, Geraldine Gonfrier, Thierry Passeron, Henri Montaudié |
| 197 |
[GO] |
2021―Oct―19 |
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience |
T. Gambichler, S. Boms, L. Susok, H. Dickel, C. Finis, N. Abu Rached, M. Barras, M. Stücker, D. Kasakovski |
| 198 |
[GO] |
2021―Oct―10 |
Recurrence of Cutaneous T-cell lymphoma (CTCL) post viral vector COVID-19 vaccination |
E Panou, V Nikolaou, L Marinos, S Kallambou, P Sidiropoulou, M Gerochristou, A Stratigos |
| 199 |
[GO] |
2021―Oct―05 |
Herpes Zoster Viral (HZV) infection after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: a case series. |
Dimitra Koumaki, Sabine-Elke Krueger-Krasagakis, Marios Papadakis, Alexander Katoulis, Vasiliki Koumaki, George Evangelou, Maria Stefanidou, Dimitris Mylonakis, Kyriaki Zografaki, Konstantinos Krasagakis |
| 200 |
[GO] |
2021―Oct―05 |
SARS-CoV-2 Serology In Patients On Biological Therapy or Apremilast For Psoriasis: A Study of 93 Patients in the Italian Red Zone |
Syed M. A. Ahmed, Martina Volontè, Eugenio Isoletta, Camilla Vassallo, Carlo Francesco Tomasini, Daniele Lilleri, Paola Zelini, Valeria Musella, Catherine Klersy, Valeria Brazzelli |
| 201 |
[GO] |
2021―Oct―05 |
Eruptive angiomatosis after SARS-CoV-2 Vaccine (Comirnaty, Pfizer) |
Corrado Zengarini, Cosimo Misciali, Tiziana Lazzarotto, Emi Dika |
| 202 |
[GO] |
2021―Sep―21 |
Are the chilblain-like lesions observed during the COVID-19 pandemic due to SARS-CoV-2? Systematic review and meta-analysis |
V. Sánchez-García, R. Hernández-Quiles, E. de-Miguel-Balsa, A. Docampo-Simón, I. Belinchón-Romero, J.M. Ramos-Rincón |
| 203 |
[GO] |
2021―Sep―21 |
Personal protective equipment use and face acne in health care providers during the COVID-19 pandemic in Romania: a new occupational acne type? |
S Cretu, M Dascalu, SR Georgescu, CM Salavastru |
| 204 |
[GO] |
2021―Sep―21 |
Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine |
Laurence Montjoye, Liliane Marot, Marie Baeck |
| 205 |
[GO] |
2021―Sep―21 |
Early atypical injection-site reactions to COVID-19 vaccine: a case series |
M. Vaccaro, L. Bertino, R. Squeri, C. Genovese, S. Isola, G. Spatari, E. Spina, P. Cutroneo |
| 206 |
[GO] |
2021―Sep―21 |
Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India |
Hitaishi Mehta, Sanjeev Handa, Pankaj Malhotra, Meenakshi Patial, Smriti Gupta, Anirudh Mukherjee, Debajyoti Chatterjee, Aastha Takkar, Rahul Mahajan |
| 207 |
[GO] |
2021―Sep―21 |
New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin? |
David Pesqué, Emilio Lopez-Trujillo, Orianna Marcantonio, Ana Maria Giménez-Arnau, Ramon Maria Pujol |
| 208 |
[GO] |
2021―Sep―21 |
A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine |
J. Young, L. Mercieca, M. Ceci, D. Pisani, A. Betts, M.J. Boffa |
| 209 |
[GO] |
2021―Sep―21 |
SARS-CoV-2 mRNA Vaccine Injection Site Pseudolymphoma |
Dillon Mintoff, Lawrence Scerri, Alexandra Betts |
| 210 |
[GO] |
2021―Sep―21 |
Pfizer-BioNTech SARS-CoV-2 mRNA Vaccine-associated Erythema Multiforme |
Luca Borg, Liam Mercieca, Dillon Mintoff, Daniel Micallef, David Pisani, Alexandra Betts, Lawrence Scerri |
| 211 |
[GO] |
2021―Sep―21 |
Erythema multiforme after SARS-CoV-2 vaccine |
Li-wen Zhang, Wen-ju Wang, Cong-hui Li, Tao Chen |
| 212 |
[GO] |
2021―Sep―21 |
Nevocentric erythema multiforme after SARS-COV-2 Vaccine |
C. Scharf, E. V. Brizzi, S. Pellerone, M. Liguori, C.M.R. Giorgio, G. Argenziano |
| 213 |
[GO] |
2021―Sep―17 |
Reply to “Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center” by Sotiriou E et al. |
M. Megna, L. Potestio, L. Gallo, G. Caiazzo, A. Ruggiero, G. Fabbrocini |
| 214 |
[GO] |
2021―Sep―07 |
Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine |
Linting Huang, Zhirong Yao, Jia Zhang |
| 215 |
[GO] |
2021―Sep―06 |
COVID-19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo, and chronic urticaria |
P.R. Criado, M. Ianhez, C.C. Silva de Castro, C. Talhari, P.M. Ramos, H.A. Miot |
| 216 |
[GO] |
2021―Sep―06 |
Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak |
EJ Chun, JK Kim, SY Yang, SS Kim, CW Kim |
| 217 |
[GO] |
2021―Sep―06 |
Erythema annulare centrifugum triggered by SARS-CoV-2 infection |
N Setó-Torrent, A Altemir, M Iglesias-Sancho, MT Fernández-Figueras |
| 218 |
[GO] |
2021―Aug―30 |
Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines |
M. Tihy, S. Menzinger, R. André, E. Laffitte, L. Toutous-Trellu, G. Kaya |
| 219 |
[GO] |
2021―Aug―21 |
The crucial role of clinicopathological correlation in COVID-19-related cutaneous manifestations |
F. Rongioletti |
| 220 |
[GO] |
2021―Aug―20 |
SARS-CoV-2 in the sweat of COVID-19 positive patients: a possible route of transmission? |
S. Recalcati, S. Tonolo, E. Meroni, F. Fantini |
| 221 |
[GO] |
2021―Aug―20 |
Flagellate Purpura Associated With COVID-19 Vaccination |
Emma Heck, Brian D. Rankin, Michelle Schneider, Vimal H. Prajapati |
| 222 |
[GO] |
2021―Aug―20 |
Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinations |
G Ciccarese, F Drago, A Rebora, A Parodi |
| 223 |
[GO] |
2021―Aug―09 |
Cutaneous reactions following CoronaVac COVID-19 vaccination: a case series of six healthcare workers from a single center |
Elçin Akdaş, Betül Öğüt, Özlem Erdem, Murat Orhan Öztaş, Nilsel İlter |
| 224 |
[GO] |
2021―Aug―07 |
Erythema Gyratum Repens after COVID-19 |
R Castro Silva, G Castro Silva, MC Castro Silva, O Lupi |
| 225 |
[GO] |
2021―Aug―07 |
Characteristics of facial skin problems and microbiome variation during wearing masks for fighting against COVID-19 |
Chenyang Huang, Qingmiao Sun, Daixi Jiang, Xiaobao Zhang, Can Chen, Danying Yan, Xiaoxiao Liu, Yuqing Zhou, Cheng Ding, Lei Lan, Jie Wu, Lanjuan Li, Ang Li, Xiaoyan Liu, Shigui Yang |
| 226 |
[GO] |
2021―Aug―07 |
Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center |
E Sotiriou, A Tsentemeidou, K Bakirtzi, A Lallas, D Ioannides, E Vakirlis |
| 227 |
[GO] |
2021―Aug―07 |
Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine) |
Lester Juay, Nisha Suyien Chandran |
| 228 |
[GO] |
2021―Aug―07 |
Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature |
E. Annabi, N. Dupin, P. Sohier, B. Garel, N. Franck, S. Aractingi, S. Guégan, B. Oulès |
| 229 |
[GO] |
2021―Aug―07 |
Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: A case series from the Philippines |
J.N. Yu, C.B. Angeles, H.G. Lim, C. Chavez, C. Roxas-Rosete |
| 230 |
[GO] |
2021―Aug―07 |
Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults |
Ahmet Kağan Özdemir, Sera Kayhan, Seray Külcü Çakmak |
| 231 |
[GO] |
2021―Aug―07 |
Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series |
Maria Vastarella, Vincenzo Picone, Fabrizio Martora, Gabriella Fabbrocini |
| 232 |
[GO] |
2021―Jul―26 |
Cutaneous manifestations of patients hospitalized with coronavirus disease 2019 (COVID-19) |
P Ramezani Darmian, Z Memarzadeh, R Aryan, Y Nahidi, Z Mehri, A taghipour, N Samimi, M Amini, P Layegh |
| 233 |
[GO] |
2021―Jul―26 |
Dermatoses caused by face mask wearing during the COVID-19 pandemic |
Olga Yu. Olisova, Natalia P. Teplyuk, Ekaterina V. Grekova, Anfisa A. Lepekhova |
| 234 |
[GO] |
2021―Jul―26 |
The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities |
Clio Dessinioti, Claus Garbe, Alexander J Stratigos |
| 235 |
[GO] |
2021―Jul―26 |
New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report |
M. Lehmann, P. Schorno, R. E. Hunger, K. Heidemeyer, L. Feldmeyer |
| 236 |
[GO] |
2021―Jul―26 |
Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine |
A. Smola, S. Samazadeh, L. Müller, O. Adams, B. Homey, P. Albrecht, S. Meller |
| 237 |
[GO] |
2021―Jul―26 |
A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine |
R. Pasternack, S. Pohjavaara |
| 238 |
[GO] |
2021―Jul―26 |
Small vessel vasculitis related to varicella zoster virus after Pfizer-BioNTech COVID-19 vaccine |
Francesca Nastro, Gabriella Fabbrocini, Francesca di Vico, Claudio Marasca |
| 239 |
[GO] |
2021―Jul―26 |
Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine |
Iñigo Lladó, Beatriz Butrón-Bris, Raquel Sampedro-Ruiz, Javier Fraga, Diego de Argila |
| 240 |
[GO] |
2021―Jul―26 |
Small vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2 |
Luisa Guzmán-Pérez, Mario Puerta-Peña, Daniel Falkenhain-López, Julia Montero-Menárguez, Christian Gutiérrez-Collar, José Luis Rodríguez-Peralto, Jimena Sanz-Bueno |
| 241 |
[GO] |
2021―Jul―26 |
Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection |
M. Brito Caldeira, M. Pestana, A. Luísa João, C. Fernandes, A. João, N. Cunha |
| 242 |
[GO] |
2021―Jul―26 |
Herpes Zoster following SARS-CoV-2 vaccination - a series of 4 cases |
M Alpalhão, P Filipe |
| 243 |
[GO] |
2021―Jul―26 |
New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: Clinical images and histopathological study of 3 cases |
D. Revilla-Nebreda, M. Roncero-Riesco, Á. Santos-Briz, M. Medina-Migueláñez, N. Segurado-Tostón, C. Román-Curto |
| 244 |
[GO] |
2021―Jul―23 |
Prevalence and characteristics of dermatological manifestations in COVID-19 positive dermatologists: Report from a web-based survey in India |
Deepak Jakhar, Anupam Das, Subuhi Kaul, Ishmeet Kaur, Bhushan Madke, Ashish Dalal |
| 245 |
[GO] |
2021―Jul―14 |
Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study |
Erica Koch, Francisco Villanueva, Michael A. Marchetti, Álvaro Abarzúa, Consuelo Cárdenas, Juan Camilo Castro, Francisco Dominguez, Katherine Droppelmann, Nicolás Droppelmann, Héctor Galindo, Augusto León, Jorge Madrid, Montserrat Molgó, Sebastián Mondaca, Pablo Montero, Pablo Uribe, Miguel A. Villaseca, Eugenio Vinés, Cristian Navarrete-Dechent |
| 246 |
[GO] |
2021―Jul―09 |
Transition of cutaneous into systemic lupus erythematosus following adenoviral vector based SARS-CoV-2 vaccination |
Alexander Kreuter, Sven-Niklas Burmann, Björn Burckert, Frank Oellig, Alena-Lioba Michalowitz |
| 247 |
[GO] |
2021―Jul―09 |
“COVID arm” - histological features of a delayed type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine |
W. Kempf, N. Kettelhack, F. Kind, S. Courvoisier, J. Galambos, K. Pfaltz |
| 248 |
[GO] |
2021―Jul―08 |
Development of eruptive pseudoangiomatosis following COVID-19 immunization- apropos of 5 cases |
Alpana Mohta, Suresh Kumar Jain, Rajesh Dutt Mehta, Aakanksha Arora |
| 249 |
[GO] |
2021―Jul―08 |
Pityriasis rosea developing after COVID-19 vaccination |
O. Marcantonio-Santa Cruz, A. Vidal-Navarro, D. Pesqué, A.M. Giménez-Arnau, R.M. Pujol, G. Martin-Ezquerra |
| 250 |
[GO] |
2021―Jul―08 |
New-onset cutaneous lichen planus triggered by COVID-19 vaccination |
R. Merhy, A.S Sarkis, J. Kaikati, L. El Khoury, S. Ghosn, F. Stephan |
| 251 |
[GO] |
2021―Jul―08 |
Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine |
AC Leasure, S Cowper, J McNiff, JM Cohen |
| 252 |
[GO] |
2021―Jul―08 |
Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine |
N. Cameli, M. Silvestri, M. Mariano, S.P. Nisticò, A. Cristaudo |
| 253 |
[GO] |
2021―Jul―08 |
New onset of Remitting Seronegative Symmetrical Synovitis with Pitting Oedema and Palmoplantar Psoriasis flare-up after Sars-Cov-2 Vaccination |
L Quattrini, L Verardi, G Caldarola, G Peluso, C De Simone, M D’Agostino |
| 254 |
[GO] |
2021―Jul―08 |
Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine. |
D Falkenhain-López, C Gutiérrez-Collar, J Arroyo-Andrés, I Gallego-Gutiérrez, JL Rodríguez-Peralto, A Sánchez-Velázquez |
| 255 |
[GO] |
2021―Jun―25 |
The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? |
Giovanni Damiani, Alessia Pacifico, Francesco Pelloni, Matilde Iorizzo |
| 256 |
[GO] |
2021―Jun―25 |
Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2 |
Farzan Solimani, Yasmine Mansour, Dario Didona, Amrei Dilling, Kamran Ghoreschi, Katharina Meier |
| 257 |
[GO] |
2021―Jun―24 |
Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’? |
Jeong Eun Kim, Hyun Lee, Seung Sam Paik, Ji-Yong Moon, Ho Joo Yoon, Sang-Heon Kim |
| 258 |
[GO] |
2021―Jun―19 |
Evolution of notified sexually transmitted infections in Barcelona during the First Wave of the COVID-19 Pandemic |
Gemma Martin-Ezquerra, Pablo Monreal, Lilas Mercuriali, Esperanza Cañas-Ruano, Ramon M Pujol, Xavier Duran, Magalí Masferrer Niubò, Pere Domingo, Judit Villar-Garcia, Joaquin Lopez-Contreras, Ana Gonzalez-Cordón, Patricia Garcia-Olalla, María-Jesús Barberá, Roger Rovira, Naseer Mohammad Porras, Marta De Antonio Cusco, Adrià Curran, Encarnación Arellano, Desideria Martínez-Rascón, Vicente Descalzo, Maider Arando, Vicenç Falcó, Hernando Knobel, Agustin Marcos Blanco, Cristina Rius Roser Clos, Eva Masdeu, Miriam Ros, Ingrid Avellanés, Raquel Prieto, Alba Artigues, Anna Hernandez, Irene Fuertes, Josep Riera, Iván Chivite |
| 259 |
[GO] |
2021―Jun―19 |
The Significance of Exanthems in COVID-19 Patients Hospitalized at a Tertiary Care Center |
Renajd Rrapi, Sidharth Chand, Jennifer A. Lo, Colleen K Gabel, Sarah Song, Zachary Holcomb, Christopher Iriarte, Kevin Moore, Connie R. Shi, Hannah Song, Fan Di Xia, Daniel Yanes, Rajesh Gandhi, Virginia A. Triant, Daniela Kroshinsky |
| 260 |
[GO] |
2021―Jun―18 |
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study |
SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, F Capon, CR Contreras, C De La Cruz, P Di Meglio, P Gisondi, D Jullien, J Lambert, L Naldi, S Norton, L Puig, P Spuls, T Torres, RB Warren, H Waweru, J Weinman, MA Brown, JB Galloway, CM Griffiths, JN Barker, CH Smith |
| 261 |
[GO] |
2021―Jun―16 |
Psoriasis flare up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine |
PK Krajewski, Ł Matusiak, JC Szepietowski |
| 262 |
[GO] |
2021―Jun―16 |
Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2 |
C. Lesort, J. Kanitakis, L. Donzier, D. Jullien |
| 263 |
[GO] |
2021―Jun―16 |
A review of nail findings associated with COVID-19 infection |
Edward Hadeler, Brian W. Morrison, Antonella Tosti |
| 264 |
[GO] |
2021―Jun―16 |
Adverse Skin Reactions Due to Use of Face Masks: A Prospective Survey during the COVID-19 Pandemic in Korea |
S.J. Park, H.S. Han, S.H. Shin, K.H. Yoo, K. Li, B.J. Kim, S.J. Seo, K.Y. Park |
| 265 |
[GO] |
2021―Jun―03 |
Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic |
Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Mario Cutrone, Iria Neri, Ramon Grimalt, Teresa Russo |
| 266 |
[GO] |
2021―Jun―02 |
Patients with Primary Cutaneous Lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry |
A. Sánchez-Velázquez, A. Bauer-Alonso, T. Estrach, D. Vega-Díez, P. Garcia-Muret, L. Haya, Y. Peñate, E. Acebo, R. Fernández de Misa, M. Blanes, HJ. Suh-Oh, R. Izu, E. Silva-Díaz, J. Sarriugarte, C. Román-Curto, R. Botella-Estrada, A. Mateu-Puchades, L. Prieto-Torres, V. Morillas, Me. Morillo, P. Sanchez-Caminero, L. Calzado, A. Pérez-Ferriols, A. Pérez, JD. Domínguez, M. Navedo, C. Muniesa, A. Combalia, J. Arroyo-Andrés, MA. Descalzo, I. García-Doval, PL. Ortiz-Romero |
| 267 |
[GO] |
2021―Jun―02 |
Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine |
PK Krajewski, JC Szepietowski |
| 268 |
[GO] |
2021―May―31 |
Ipsilateral Herpes Zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine |
Ioannis Tessas, Nicolas Kluger |
| 269 |
[GO] |
2021―May―31 |
Acute postinfectious Pityriasis Rubra Pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features. |
D. Kadylak, W. Barańska-Rybak |
| 270 |
[GO] |
2021―May―28 |
Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle? |
C. Mazzatenta, V. Piccolo, G. Pace, I. Romano, G. Argenziano, A. Bassi |
| 271 |
[GO] |
2021―May―26 |
Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic |
Parna Moghadam, Laure Frumholtz, Léa Jaume, Adèle De Masson, Marie Jachiet, Edouard Begon, Luc Sulimovic, Antoine Petit, Hervé Bachelez, Martine Bagot, Jean-David Bouaziz, Charles Cassius |
| 272 |
[GO] |
2021―May―26 |
Dapsone induced methemoglobinemia in leprosy: A close mimic of ‘happy hypoxia’ in the COVID-19 pandemic |
Tanu Tripathi, Anchit Raj Singh, Rajan Kapoor, Anwita Sinha, Saikat Ghosh, Kanwaljit Kaur, Deepak Pokhariya, Shyamal Maity, Anindya Tapadar, Alok Chandra |
| 273 |
[GO] |
2021―May―26 |
SARS-CoV-2 mRNA Vaccine-Associated Fixed Drug Eruption |
Dillon Mintoff, David Pisani, Alexandra Betts, Lawrence Scerri |
| 274 |
[GO] |
2021―May―25 |
Urticarial Vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg? |
Paulo Ricardo Criado, Roberta Fachini Jardim Criado, Raffaele Gianotti, Beatrice Artinez Zugaib Abdalla, Thais Prota Hussein Pincelli, Alexandre Osores Michalany, Nilceo Schwery Michalany |
| 275 |
[GO] |
2021―May―22 |
Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy |
E. Farinazzo, G. Ponis, E. Zelin, E. Errichetti, G. Stinco, C. Pinzani, A. Gambelli, N. De Manzini, L. Toffoli, A. Moret, M. Agozzino, C. Conforti, N. Di Meo, P. Schincariol, I. Zalaudek |
| 276 |
[GO] |
2021―May―20 |
Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology |
Laura Giraud-Kerleroux, Margaux Mongereau, Charles Cassius, Marc Mrad, Charlotte Gary, Caroline Fiani, Marouane Ben Kahla, Thibault Mahevas, Elina Zuelgaray, Charbel Skayem, Camille Hua, Khaled Ezzedine, Martine Bagot, Jean-David Bouaziz, Tu Anh Duong |
| 277 |
[GO] |
2021―May―20 |
Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection |
A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, MC Durand-Muñoz, GL Mena-Hernández, YK Melchor-Mendoza, AL Ruelas-Villavicencio, A García-Irigoyen, GA Acatitla-Acevedo, S Toussaint-Caire, J Domínguez-Cherit |
| 278 |
[GO] |
2021―May―20 |
SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations |
B Cribier, C Taieb, M Saint Aroman, J Shourick |
| 279 |
[GO] |
2021―May―14 |
Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19 |
Betul Demir, Esma Inan Yuksel, Demet Cicek, Sedatcan Turkoglu |
| 280 |
[GO] |
2021―May―13 |
Androgenetic alopecia in women and men is not related to COVID-19 infection severity: A prospective cohort study of hospitalized COVID-19 patients |
Shatila Torabi, Mahnaz Mozdourian, Roxana Rezazadeh, Abolfazl Payandeh, Shapour Badiee, Emadodin Darchini-Maragheh |
| 281 |
[GO] |
2021―May―13 |
Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccine |
M Gyldenløve, L Skov, CB Hansen, P Garred |
| 282 |
[GO] |
2021―May―13 |
Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine |
Benoit Cyrenne, Faisal Al-Mohammedi, Joel DeKoven, Raed Alhusayen |
| 283 |
[GO] |
2021―Apr―29 |
Adamantiades-Behçet’s disease (Behçet’s disease) and COVID-19 |
C.C. Zouboulis, J.A.M. Laar, M. Schirmer, G. Emmi, F. Fortune, A. Gül, Y. Kirino, E.-S. Lee, P.P. Sfikakis, F. Shahram, G.R. Wallace |
| 284 |
[GO] |
2021―Apr―29 |
Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology |
R Guelimi, R Salle, L Dousset, H Assier, S Fourati, Z Bhujoo, S Barbarot, C Boulard, C Cazanave, A Colin, E Kostrzewa, C Lesort, A Levy Roy, F Lombart, J Marco Bonnet, L. Marty, JB Monfort, L. Riffaud, M Samimi, M Tardieu, E Sbidian, P Wolkenstein, L Le Cleach, M Beylot-Barry |
| 285 |
[GO] |
2021―Apr―29 |
Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report |
Elçin Akdaş, Nilsel İlter, Betül Öğüt, Özlem Erdem |
| 286 |
[GO] |
2021―Apr―29 |
BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2 |
Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Mario Cutrone, Iria Neri, Ramon Grimalt, Teresa Russo |
| 287 |
[GO] |
2021―Apr―26 |
“Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance” |
JM Busto-Leis, G Servera-Negre, A Mayor-Ibarguren, E Sendagorta-Cudós, M Feito-Rodríguez, A Nuño-González, MD Montero-Vega, P Herranz-Pinto |
| 288 |
[GO] |
2021―Apr―20 |
Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicenter retrospective cohort study |
Jorge R. Georgakopoulos, Asfandyar Mufti, Ron Vender, Vimal H. Prajapati, Jensen Yeung |
| 289 |
[GO] |
2021―Apr―19 |
Covid-19-triggered sarcoidal granulomas mimicking scar sarcoidosis |
A Polat Ekinci, N Büyükbabani, S Meşe, G Pehlivan, NG Okumuş, A Ağaçfidan, E Özkaya |
| 290 |
[GO] |
2021―Apr―19 |
Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2? |
S Signa, AR Sementa, MC Coccia, C Pastorino, G Viglizzo, S Viola, S Volpi, C Occella, D Bleidl, M Acquila, E Castagnola, A Ravelli, F Manunza |
| 291 |
[GO] |
2021―Apr―18 |
Adverse skin reactions related to PPE among health care workers managing COVID-19 |
Priyanka Sharma, Nainika Goel, Kanika Dogar, Mala Bhalla, GP Thami, Kavita Punia |
| 292 |
[GO] |
2021―Apr―18 |
Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology? |
C Cassius, L Frumholtz, A de Masson, O Dadzie, A Petit |
| 293 |
[GO] |
2021―Apr―18 |
Penile ischemia secondary to COVID-19: Why should the dermatologist be concerned? |
P. Sarkis, J. Sarkis, M. Alkassis, J. Assaf, K. El Gharib |
| 294 |
[GO] |
2021―Apr―09 |
Good tolerance of hyaluronic acid injections during the period of the Covid-19 pandemic: observing a cohort of 1093 patients in a prospective, observational real-life study |
Michael Naouri, Serge Dahan, Anne Le Pillouer Prost, Phrynée Coutant-Foulc, Catherine Raimbault, Françoise Cucurella, Laurence Beille, Muriel Creusot, Martine Baspeyras, Martine Darchy, Randa Khallouf, Hugues Cartier, Isabelle Baratte, Magali Dubois, Olivier Cogrel, Hans Laubach |
| 295 |
[GO] |
2021―Apr―09 |
Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single centre case series |
M. Corbeddu, A. Diociaiuti, MR. Vinci, A. Santoro, V. Camisa, S. Zaffina, M. El Hachem |
| 296 |
[GO] |
2021―Apr―08 |
Nail changes as manifestation of systemic disease in COVID-19 infection |
SS Ocampo-Garza, J Ocampo-Candiani, E Camela, M Vastarella, G Fabbrocini, M Scalvenzi, A Villani |
| 297 |
[GO] |
2021―Mar―30 |
Extraordinary Claims Without Extraordinary Evidence Controversy on Anti-Androgen Therapy for COVID-19 |
R.M. Trüeb, A. Régnier, N. Caballero-Uribe, M.F. Reis Gavazzoni Dias, H. Dutra Rezende |
| 298 |
[GO] |
2021―Mar―30 |
Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine. |
M Ackerman, D Henry, A Finon, R Binois, E Esteve |
| 299 |
[GO] |
2021―Mar―30 |
Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. “COVID-arm”: a clinical and histological characterization |
D. Fernandez-Nieto, J. Hammerle, M. Fernandez-Escribano, CM Moreno-del Real, P. Garcia-Abellas, I. Carretero-Barrio, E. Solano-Solares, B de-la-Hoz-Caballer, J. Jimenez-Cauhe, D. Ortega-Quijano, M. Fernandez-Guarino |
| 300 |
[GO] |
2021―Mar―29 |
Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19 |
M. Arenbergerova, A. Lallas, E. Nagore, L. Rudnicka, A. Forsea, M. Pasek, F. Meier, K. Peris, J. Olah, C. Posch |
| 301 |
[GO] |
2021―Mar―29 |
A new virtual inpatient dermatology electronic referral service: a timely solution in the COVID-19 pandemic and beyond? |
A Lowe, A Pararajasingam, FM Ali, S Dawood, CD Lowe, NM Stone |
| 302 |
[GO] |
2021―Mar―29 |
VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should know |
F. Diotallevi, A. Campanati, G. Radi, E. Martina, G. Rizzetto, P Barbadoro, M.M. D’Errico, A. Offidani |
| 303 |
[GO] |
2021―Mar―22 |
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts |
J Ring, M Worm, A Wollenberg, JP Thyssen, T Jakob, L Klimek, C Bangert, S Barbarot, T Bieber, MS de Bruin-Weller, PV Chernyshov, S Christen-Zaech, M Cork, U Darsow, C Flohr, R Fölster-Holst, C Gelmetti, U Gieler, J Gutermuth, A Heratizadeh, DJ Hijnen, LB von Kobyletzki, B Kunz, C Paul, Julien Seneschal, D Simon, PI Spuls, JF Stalder, A Svensson, Z Szalai, A Taieb, A Torrelo, M Trzeciak, T Werfel, S Weidinger, M Deleuran |
| 304 |
[GO] |
2021―Mar―17 |
Follow-up of dermatological manifestations in non-critical hospitalized patients with COVID-19 pneumonia and their prognostic correlation with disease severity |
A García-Irigoyen, GA Acatitla-Acevedo, A Barrera-Godínez, S Méndez-Flores, J Domínguez-Cherit |
| 305 |
[GO] |
2021―Mar―16 |
COVID-19 pandemic and autoimmune bullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation |
M. Kasperkiewicz, M. Yale, R. Strong, D. Zillikens, D.T. Woodley, A. Recke |
| 306 |
[GO] |
2021―Mar―16 |
Periocular capillaritis in a COVID-19 positive patient: report of a case |
A Paganelli, F Garbarino, L Bigi |
| 307 |
[GO] |
2021―Mar―16 |
Lichen planus arising after COVID-19 vaccination |
I. Hiltun, J. Sarriugarte, I. Martínez-de-Espronceda, A. Garcés, C. Llanos, R. Vives, J.I. Yanguas |
| 308 |
[GO] |
2021―Mar―16 |
Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccination |
T. Gambichler, L. Scholl, L. Ocker, R. Stranzenbach |
| 309 |
[GO] |
2021―Mar―03 |
Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic |
M. Kasperkiewicz, E. Schmidt, M. Amagai, J.A. Fairley, P. Joly, D.F. Murrell, A.S. Payne, M.L. Yale, D. Zillikens, D.T. Woodley |
| 310 |
[GO] |
2021―Mar―02 |
Association Between COVID-19 and Chilblains: A Case-Control Study |
Daniel Ortega-Quijano, Diego Fernandez-Nieto, Juan Jimenez-Cauhe, Jose Luis Cortes-Cuevas, Daniel Marcos-Mencia, Mario Rodriguez-Dominguez, Gonzalo Segurado-Miravalles, Montserrat Fernandez-Guarino, Pedro Jaen-Olasolo |
| 311 |
[GO] |
2021―Mar―02 |
Insights into COVID-19 vaccination in patients with chronic plaque psoriasis on systemic treatments |
P Gisondi, D Geat, L Naldi, S Piaserico |
| 312 |
[GO] |
2021―Mar―02 |
Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late onset skin manifestation in previously infected individuals |
Iria Neri, Francesca Conti, Annalucia Virdi, Alba Guglielmo, Lucia Leonardi, Ilaria Corsini, Chiara Ghizzi, Liliana Gabrielli, Tiziana Lazzarotto, Marcello Lanari, Annalisa Patrizi, Cosimo Misciali |
| 313 |
[GO] |
2021―Feb―18 |
European Task Force on Atopic Dermatitis (ETFAD): position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics |
Jacob P. Thyssen, Christian Vestergaard, Sebastien Barbarot, Marjolein S. de Bruin-Weller, Thomas Bieber, Alain Taieb, Julien Seneschal, Michael J Cork, Carle Paul, Carsten Flohr, Stephan Weidinger, Magdalena Trzeciak, Thomas Werfel, Annice Heratizadeh, Ulf Darsow, Dagmar Simon, Antonio Torrelo, Pavel V. Chernyshov, Jean-Francois Stalder, Carlo Gelmetti, Zsuzsanna Szalai, Åke Svensson, Laura B von Kobyletzki, Linda De Raeve, Regina Fölster-Holst, Stéphanie Christen-Zaech, Dirk Jan Hijnen, Uwe Gieler, Jan Gutermuth, Christine Bangert, Phyllis I. Spuls, Barbara Kunz, Johannes Ring, Andreas Wollenberg, Mette Deleuran |
| 314 |
[GO] |
2021―Feb―15 |
Relapse of chilblain-like lesions during the second wave of COVID-19 |
S. Recalcati, T. Barbagallo, S. Tonolo, M. Milani, F. Fantini |
| 315 |
[GO] |
2021―Feb―15 |
COVID-19 and immune checkpoint inhibitors |
M.S. Ahmed, H. Brehme, S. Friedrich, L. Reinhardt, S. Blum, S. Beissert, F. Meier |
| 316 |
[GO] |
2021―Feb―15 |
An Irish Department of Genito-Urinary Medicine in the COVID-19 Era |
D. Moriarty, C O’Connor, J. Bourke, M Murphy, M. Horgan, S Cremin |
| 317 |
[GO] |
2021―Feb―15 |
Concerns and perceptions of patients with psoriatic disease during the COVID-19 pandemic: results from a two-wave survey by the National Psoriasis Foundation |
G.C. Gondo, S.J. Bell, J. Slayden, G. Ullmann, A. Blauvelt |
| 318 |
[GO] |
2021―Feb―15 |
Rapidly progressive alopecia areata totalis in a Covid-19 patient, unresponsive to tofacitinib |
S. Berbert Ferreira, M.F.R. Gavazzoni Dias, R. Berbert Ferreira, A.C. Neves Neto, R.M. Trüeb, O. Lupi |
| 319 |
[GO] |
2021―Feb―15 |
Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? |
S. Piaserico, P. Gisondi, S. Cazzaniga, G. Girolomoni, PG. Calzavara-Pinton, L. Naldi |
| 320 |
[GO] |
2021―Feb―06 |
Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR |
MF García-Gil, J Monte-Serrano, M García García, Lucia Prieto-Torres, AJ Pascual-del-Riquelme, I Casas Flecha, M Ara-Martín |
| 321 |
[GO] |
2021―Feb―06 |
Chilblain-like lesions and COVID-19: second wave, second outbreak |
Vincenzo Piccolo, Andrea Bassi, Teresa Russo, Carlo Mazzatenta, Maura Baraldi, Giuseppe Argenziano, Iria Neri, Mario Cutrone |
| 322 |
[GO] |
2021―Feb―06 |
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond |
J. Beecker, K.A. Papp, J. Dutz, R.B. Vender, R. Gniadecki, C. Cooper, P. Gisondi, M. Gooderham, C.H. Hong, M.G. Kirchhof, C.W. Lynde, C. Maari, Y. Poulin, L. Puig |
| 323 |
[GO] |
2021―Jan―18 |
COVID-19 and HHV8 first spotted together: an affair under electron microscopy |
E. Leoni, M. Cerati, G. Finzi, M. Lombardo, F. Sessa |
| 324 |
[GO] |
2021―Jan―15 |
Dermato-venereology in the year of coronavirus - Hot topics in research and patient care |
J. Ring |
| 325 |
[GO] |
2020―Dec―23 |
COVID-19 has changed our society as well as Dermatology |
J. Ring |
| 326 |
[GO] |
2020―Dec―23 |
Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines |
E. Papadavid, J. Scaribrick, P. Ortiz Romero, P. Quaglino, M. Vermeer, R. Knobler, R. Stadler, M. Bagot |
| 327 |
[GO] |
2020―Dec―18 |
Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic |
Karan Pandher, Caroline L. Porter, Hiral S. Patel, William W. Huang, Steven R. Feldman |
| 328 |
[GO] |
2020―Dec―09 |
Palmoplantar erythrodysestesia: a diagnostic sign of COVID-19 |
Almudena Nuno-Gonzalez, Kyrylo Magaletsky, Marta Feito Rodríguez, Ander Mayor Ibarguren, Maria Jose Beato, Elena Ruiz Bravo, Pedro Herranz Pinto |
| 329 |
[GO] |
2020―Dec―01 |
Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant. A cross-sectional study. |
D. Fernandez-Nieto, D. Ortega-Quijano, A. Suarez-Valle, J. Jimenez-Cauhe, P. Jaen-Olasolo, M. Fernandez-Guarino |
| 330 |
[GO] |
2020―Dec―01 |
Pityriasis rosea as a leading manifestation of COVID-19 infection |
R. Merhy, A.S Sarkis, F. Stephan |
| 331 |
[GO] |
2020―Nov―21 |
Adverse skin reactions following different types of mask usage during the COVID-19 pandemic |
Chayada Chaiyabutr, Thanisorn Sukakul, Chutipon Pruksaeakanan, Janista Thumrongtharadol Waranya Boonchai |
| 332 |
[GO] |
2020―Nov―21 |
Impact of the COVID-19 Pandemic on Inpatient Dermatology: A Multicenter Study from Hubei, China |
Yamin Zhang, Jingjing Wen, Mahin Alamgir, Jun Xie, Haixia Jing, Muping Fang, Jianxiu Wang, Meng Zhang, Zudong Meng, Liu Yang, Juan Tao |
| 333 |
[GO] |
2020―Nov―21 |
SARS-CoV-2-induced telogen effluvium: a multicentric study |
O.M. Moreno-Arrones, A. Lobato-Berezo, A. Gomez-Zubiaur, S. Arias-Santiago, D. Saceda-Corralo, C. Bernardez-Guerra, R. Grimalt, P. Fernandez-Crehuet, J. Ferrando, R. Gil, A. Hermosa-Gelbard, R. Rodrigues-Barata, D. Fernandez-Nieto, S. Merlos-Navarro, S. Vañó-Galván |
| 334 |
[GO] |
2020―Nov―02 |
Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients |
Hélio Amante Miot, Mayra Ianhez, Paulo Müller Ramos |
| 335 |
[GO] |
2020―Nov―02 |
5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia |
John McCoy, Flávio Adsuara Cadegiani, Carlos Gustavo Wambier, Sabina Herrera, Sergio Vaño-Galván, Natasha Atanaskova Mesinkovska, Paulo Müller Ramos, Jerry Shapiro, Rodney Sinclair, Antonella Tosti, Andy Goren |
| 336 |
[GO] |
2020―Nov―01 |
COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data |
L.E.M. de Wijs, M.M. Joustra, J.I. Olydam, T. Nijsten, D.J. Hijnen |
| 337 |
[GO] |
2020―Oct―22 |
Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19 |
FA Cadegiani, RK Lim, A Goren, J McCoy, M Situm, M Kovacevic, S Vañó Galván, R Sinclair, A Tosti, CG Wambier |
| 338 |
[GO] |
2020―Oct―22 |
Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection? |
A. Diociaiuti, S. Giancristoforo, S. Terreri, M. Corbeddu, C. Concato, M. Ciofi Degli Atti, G. Zambruno, R. Carsetti, M. El Hachem |
| 339 |
[GO] |
2020―Oct―20 |
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic |
K. Hansel, A. Zangrilli, L. Bianchi, K. Peris, A. Chiricozzi, A. Offidani, F. Diotallevi, M.C. Fargnoli, M. Esposito, P. Amerio, G. Gualdi, L. Bianchi, L. Stingeni |
| 340 |
[GO] |
2020―Oct―20 |
Increase in sexually transmitted infection during the COVID-19 pandemic in Taiwan |
Kun-Kuang Lee, Chih-Cheng Lai, Chien-Ming Chao, Hung-Jen Tang |
| 341 |
[GO] |
2020―Oct―12 |
Diagnosis of hair disorders during the COVID-19 pandemic: An introduction to teletrichoscopy |
M. Randolph, A. Al-alola, A. Tosti |
| 342 |
[GO] |
2020―Oct―03 |
Why are chilblains underreported in Nordic countries during the COVID-19 pandemic? An analysis of Google trends |
Nicolas Kluger |
| 343 |
[GO] |
2020―Oct―03 |
Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2 |
L. Fertitta, A. Welfringer, A. Ouedrani, L. Polivka, S. Chhun, L. Chatenoud, J. Fourgeaud, S. Hadj-Rabia, S. Temmam, M. Eloit, C. Bodemer |
| 344 |
[GO] |
2020―Oct―01 |
SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion |
T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres-Reyes, R. Schlottmann, W.E. Schmidt, R. Hayajneh, A. Sriram, J.C. Becker |
| 345 |
[GO] |
2020―Sep―27 |
“Occupational dermatoses from Personal Protective Equipment during the COVID-19 pandemic in the tropics - A Review” |
HC Lee, CL Goh |
| 346 |
[GO] |
2020―Sep―26 |
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men |
Andy Goren, Carlos Gustavo Wambier, Sabina Herrera, John McCoy, Sergio Vaño-Galván, Francesca Gioia, Belen Comeche, Raquel Ron, Sergio Serrano-Villar, Paulo Müller Ramos, Flávio Adsuara Cadegiani, Maja Kovacevic, Antonella Tosti, Jerry Shapiro, Rodney Sinclair |
| 347 |
[GO] |
2020―Sep―25 |
Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients |
John McCoy, Carlos Gustavo Wambier, Sabina Herrera, Sergio Vaño-Galván, Francesca Gioia, Belen Comeche, Raquel Ron, Sergio Serrano-Villar, Rafal M Iwasiow, Michael A Tayeb, Flávio Adsuara Cadegiani, Natasha Atanaskova Mesinkovska, Jerry Shapiro, Rodney Sinclair, Andy Goren |
| 348 |
[GO] |
2020―Sep―24 |
Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19 |
Tetsuo Shiohara, Yoshiko Mizukawa |
| 349 |
[GO] |
2020―Sep―01 |
Cutaneous Symptoms of Patients Diagnosed with Covid-19 in One Province: A Cross-Sectional Survey |
Eda Öksüm Solak, Burcu Baran Ketencioglu, Hümeyra Aslaner, Salih Levent Çinar, Demet Kartal, Ali Ramazan Benli, Murat Borlu |
| 350 |
[GO] |
2020―Sep―01 |
Frequent hand washing and disinfection-a potential new trigger for aquagenic wrinkling of the palms caused by COVID-19 outbreak |
Yukimasa Tai, Takeshi Fukumoto, Masahiro Oka, Chikako Nishigori |
| 351 |
[GO] |
2020―Sep―01 |
How the use of surgical masks during COVID-19 pandemic can induce skin effects |
S. Veronese, P. Bernardi, A. Sbarbati |
| 352 |
[GO] |
2020―Sep―01 |
Generalized Pustular Figurate Erythema. First Report in Two COVID-19 Patients on Hydroxychloroquine |
I. Abadías-Granado, A.M. Palma-Ruiz, P.A. Cerro, A.M. Morales-Callaghan, M.C. Gómez-Mateo, Y. Gilaberte, R.A. Schwartz |
| 353 |
[GO] |
2020―Sep―01 |
Skin manifestations in COVID-19 provide a clue for disease’s pathophysiology understanding |
AA Kubanov, DG Deryabin |
| 354 |
[GO] |
2020―Aug―31 |
Chilblains and COVID-19: further evidence against a causal association |
Marie Baeck, Caroline Peeters, Anne Herman |
| 355 |
[GO] |
2020―Aug―27 |
Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: “
Killing 2 birds with one ston
e” |
M. Saha, A. D’Cruz, N. Paul, R. Healy, D. Collins, D-A. Charles, S. Sahu, A. Fonia |
| 356 |
[GO] |
2020―Aug―27 |
COVID-19-related cutaneous manifestations associated with multiple drug sensitization as shown by lymphocyte transformation test |
Jun Hayakawa, Hiroki Takakura, Yoshiko Mizukawa, Tetsuo Shiohara |
| 357 |
[GO] |
2020―Aug―27 |
Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic |
Isabel Martínez-Pallás, Beatriz Aldea-Manrique, Mar Ramírez-Lluch, José Manuel Vinuesa-Hernando, Mariano Ara-Martín |
| 358 |
[GO] |
2020―Aug―27 |
Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles |
Iria Neri, Annalisa Patrizi, Liliana Gabrielli, Annalucia Virdi, Giulia Veronesi, Ilaria Corsini, Tiziana Lazzarotto, Marcello Lanari, Cosimo Misciali, Alba Guglielmo |
| 359 |
[GO] |
2020―Aug―13 |
Recommendations for skin cancer consultation and surgery during COVID-19 pandemic |
L. Brochez, J.F. Baurain, V. Del Marmol, A. Nikkels, V. Kruse, F. Sales, M. Stas, A. Van Laethem, M. Garmyn |
| 360 |
[GO] |
2020―Aug―12 |
Delayed melanoma diagnosis in the COVID-19 era: Increased breslow thickness in primary melanomas seen after the COVID-19 lockdown |
F. Ricci, L. Fania, A. Paradisi, G. Di Lella, S. Pallotta, L. Sobrino, A. Panebianco, G. Annessi, D. Abeni |
| 361 |
[GO] |
2020―Aug―12 |
Severe COVID-19 outcomes in patients with psoriasis |
X.T. Lima, M.A. Cueva, E.M Lopes, M.B. Alora |
| 362 |
[GO] |
2020―Aug―12 |
Concerns related to the COVID-19 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey |
Nikolai Dyrberg Loft, Anne-Sofie Halling, Lars Iversen, Christian Vestergaard, Mette Deleuran, Mads Kirchheiner Rasmussen, Claus Zachariae, Jacob P. Thyssen, Lone Skov |
| 363 |
[GO] |
2020―Aug―03 |
A survey on teledermatology (td) use and doctors’ perception in times of COVID-19 |
Elvira Moscarella, Paola Pasquali, Elisa Cinotti, Linda Tognetti, Giuseppe Argenziano, Pietro Rubegni |
| 364 |
[GO] |
2020―Jul―31 |
Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19 |
Anne Herman, Marine Matthews, Margaux Mairlot, Laura Nobile, Laetiia Fameree, Luc-Marie Jacquet, Marie Baeck |
| 365 |
[GO] |
2020―Jul―31 |
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy |
M Talamonti, M Galluzzo, A Chiricozzi, P Quaglino, G Fabbrocini, P Gisondi, A V Marzano, C Potenza, A Conti, A Parodi, A Belloni Fortina, F Bardazzi, G Argenziano, F Rongioletti, L Stingeni, G Micali, F Loconsole, M Venturini, MR Bongiorno, C Feliciani, P Rubegni, P Amerio, MC Fargnoli, P Pigatto, P Savoia, SP Nisticò, S Giustini, A Carugno, SP Cannavò, G Rech, F Prignano, A Offidani, M Lombardo, I Zalaudek, L Bianchi, K Peris, R Balestri, N Bernardini, E Botti, M Burlando, G Caldarola, A Cattaneo, P Dapavo, S Dastoli, C De Simone, S Di Nuzzo, F Diotallevi, MT Fierro, R Fidanza, C Foti, DM Gambini, A Gambardella, G Girolomoni, C Guarneri, G Gualdi, M Megna, C Mugheddu, ML Musumeci, A Patrizi, G Pellacani, S Piaserico, AG Richetta, E Rosi, MT Rossi, L Sacchelli, R Tiberio, G Tilotta, E Trovato, R Vezzoni, A Zangrilli |
| 366 |
[GO] |
2020―Jul―17 |
The skin in the era of coronavirus pandemic |
J. Ring |
| 367 |
[GO] |
2020―Jul―11 |
STIs and the COVID-19 pandemic: the lockdown does not stop sexual infections |
R. Balestri, M. Magnano, L. Rizzoli, S.D. Infusino, F. Urbani, G. Rech |
| 368 |
[GO] |
2020―Jul―03 |
Concurrent chilblains and retinal vasculitis in a child with COVID-19 |
Lucía Quintana-Castanedo, Marta Feito-Rodríguez, Celia Fernández-Alcalde, María Granados-Fernández, Dolores Montero-Vega, Ander Mayor-Ibarguren, Raúl de Lucas-Laguna |
| 369 |
[GO] |
2020―Jul―03 |
Dermoscopy features of COVID-19-related chilblains in children and adolescents |
Lourdes Navarro, David Andina, Lucero Noguera-Morel, Angela Hernández-Martín, Isabel Colmenero, Antonio Torrelo |
| 370 |
[GO] |
2020―Jun―28 |
COVID-19 and cutaneous manifestations: A systematic review |
Qing Zhao, Xiaokai Fang, Zheng Pang, Bowen Zhang, Hong Liu, Furen Zhang |
| 371 |
[GO] |
2020―Jun―28 |
COVID-19 and outbreak of chilblains: are they related? |
C. Lesort, J. Kanitakis, A. Villani, E. Ducroux, P. Bouschon, K. Fattouh, B. Bensaid, M. Danset, D. Jullien |
| 372 |
[GO] |
2020―Jun―28 |
Prior treatment with immunosuppressants among COVID-19 inpatients at one hospital in Spain |
MA Pastor-Nieto, P Checa-Díaz, P González-Muñoz, A Martín-Fuentes, A Vergara-Sánchez, C Sánchez-Herreros, E Jiménez-Blázquez, R Cabana-Navia, J Martínez-Mariscal, Pablo Cobo-Rodríguez, Iván Checa-Recio, ME Gatica-Ortega, M Torralba, E De Eusebio-Murillo |
| 373 |
[GO] |
2020―Jun―28 |
COVID-19 Lockdown induced acral dermatosis in children |
Nathalie Bodak, Christine Chiaverini, Sebastien Barbarot |
| 374 |
[GO] |
2020―Jun―28 |
Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech Republic |
F Rob, J Hugo, S Tivadar, P Boháč, S Gkalpakiotis, N Vargová, M Arenbergerová, J Hercogová |
| 375 |
[GO] |
2020―Jun―27 |
Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature |
S. Matar, B. Oulès, P. Sohier, O. Chosidow, M. Beylot-Barry, N. Dupin, S. Aractingi |
| 376 |
[GO] |
2020―Jun―27 |
Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience |
Marta García-Legaz Martínez, Álvaro Martínez-Doménech, Jorge Magdaleno-Tapial, Cristian Valenzuela-Oñate, Felipe Partarrieu-Mejías, Javier Lorca-Spröhnle, Andrés Casanova-Esquembre, Amparo Pérez-Ferriols, Víctor Alegre-de Miquel |
| 377 |
[GO] |
2020―Jun―27 |
Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection |
J. Rouanet, E. Lang, F. Beltzung, B. Evrard, C. Henquell, I. Joulie, M. D’Incan |
| 378 |
[GO] |
2020―Jun―26 |
Relapsing symmetric livedo reticularis in a patient with COVID-19 infection |
M. Verheyden, M. Grosber, J. Gutermuth, B. Velkeniers |
| 379 |
[GO] |
2020―Jun―25 |
Cutaneous manifestations of SARS-CoV-2 infection: a clinical update |
P Gisondi, S PIaserico, C Bordin, M Alaibac, G Girolomoni, L Naldi |
| 380 |
[GO] |
2020―Jun―21 |
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19 |
Anne-Claire Fougerousse, Marc Perrussel, Pierre-André Bécherel, Edouard Begon, Valérie Pallure, Ines Zaraa, Guillaume Chaby, Josiane Parier, Mathilde Kemula, Laure Mery-Bossard, Claire Poreaux, Charles Taieb, François Maccari, Ziad Reguiai |
| 381 |
[GO] |
2020―Jun―19 |
‘’Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece’’ |
Authors: E Vakirlis, K Bakirtzi, I Papadimitriou, F Vrani, N Sideris, A Lallas, D Ioannides, E Sotiriou |
| 382 |
[GO] |
2020―Jun―19 |
An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient |
S. Negrini, A. Guadagno, M. Greco, A. Parodi, M. Burlando |
| 383 |
[GO] |
2020―Jun―18 |
Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy |
P Del Giudice, D Boudoumi, B Le Guen, M Reverte, J Gutnecht, JP Lacour, JP Kraemer, A Motard, M Roa |
| 384 |
[GO] |
2020―Jun―18 |
Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection |
Maria Carmela Annunziata, Angela Patrì, Angelo Ruggiero, Adriana Di Guida, Claudia Menicanti, Vincenzo Greco, Gabriella Fabbrocini |
| 385 |
[GO] |
2020―Jun―16 |
Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19 |
N Martínez Campayo, JI Bugallo Sanz, I Mosquera Fajardo |
| 386 |
[GO] |
2020―Jun―14 |
Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom |
Sofia Hadjieconomou, Jenny Hughes, Sandeep Kamath |
| 387 |
[GO] |
2020―Jun―14 |
The red half moon nail sign: a novel manifestation of Coronavirus infection |
Iria Neri, Alba Guglielmo, Annalucia Virdi, Valeria Gaspari, Michela Starace, Bianca Maria Piraccini |
| 388 |
[GO] |
2020―Jun―14 |
SARS-CoV-2, skin lesions and the need of a multidisciplinary approach |
R. Cabrera-Hernández, E. Solano-Solares, V. Chica-Guzmán, M. Fernández-Guarino, D. Fernández-Nieto, D. Ortega-Quijano, A. de-Andrés-Martín, C. Moreno, I. Carretero-Barrio, P. García-Abellás, D. González-de-Olano, B. de-la-Hoz-Caballer |
| 389 |
[GO] |
2020―Jun―13 |
Major cluster of pediatric “ true ” primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown |
Neri Iria, Virdi Annalucia, Corsini Ilaria, Guglielmo Alba, Lazzarotto Tiziana, Gabrielli Liliana, Misciali Cosimo, Patrizi Annalisa, Lanari Marcello |
| 390 |
[GO] |
2020―Jun―13 |
Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization |
C. Bitar, M.P. Chan, P.W. Harms, D.R. Fullen, J.E. Gudjonsson, M. Eshaq, S. Renati, A.B. Nikle, A. Allen, S.D. Hawkins, T. Huerta, L. Lowe, A.A. Andea |
| 391 |
[GO] |
2020―Jun―13 |
Teledermatology for acne during COVID-19: high patients’ satisfaction in spite of the emergency |
Angelo Ruggiero, Matteo Megna, Maria Carmela Annunziata, Luisa Abategiovanni, Massimiliano Scalvenzi, Andrea Tajani, Gabriella Fabbrocini, Alessia Villani |
| 392 |
[GO] |
2020―Jun―13 |
Cutaneous autoimmune diseases during COVID 19 pandemic |
C Günther, R Aschoff, S Beissert |
| 393 |
[GO] |
2020―Jun―12 |
A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19 |
V. Caputo, J. Schroeder, F. Rongioletti |
| 394 |
[GO] |
2020―Jun―12 |
Two cases of cutaneous eruptions due to CoVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology |
Benjamin Wen Yang Ho, Dingyuan Wang, Llewelyn Yi Chang Tan, Manish Mahadeorao Bundele, Chee Hian Tan, Joel Hua-Liang Lim |
| 395 |
[GO] |
2020―Jun―12 |
Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description |
J. Larrondo, R. Cabrera, M. Gosch, F. Larrondo, M. Aylwin, A. Castro |
| 396 |
[GO] |
2020―Jun―11 |
The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases |
C.A. Rubio-Muniz, M. Puerta-Peña, D. Falkenhain-López, J. Arroyo-Andrés, M. Agud-Dios, J.L. Rodriguez-Peralto, P.L. Ortiz-Romero, R. Rivera-Díaz |
| 397 |
[GO] |
2020―Jun―11 |
SARS-CoV, Mers-CoV and Covid-19:what differences from a dermatological viewpoint? |
Franco Rongioletti |
| 398 |
[GO] |
2020―Jun―08 |
Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? |
D. de Perosanz-Lobo, D. Fernandez-Nieto, P. Burgos-Blasco, G. Selda-Enriquez, I. Carretero, C. Moreno, M. Fernández-Guarino |
| 399 |
[GO] |
2020―Jun―05 |
Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not “varicella-like” |
A. Mahé, E. Birckel, C. Merklen, P. Lefèbvre, C. Hannedouche, M. Jost, L. Droy-Dupré |
| 400 |
[GO] |
2020―Jun―04 |
Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic |
PV Chernyshov, L Tomas-Aragones, M Augustin, A Svensson, A Bewley, F Poot, JC Szepietowski, SE Marron, L Manolache, N Pustisek, A Suru, CM Salavastru, C Blome, MS Salek, D Abeni, F Sampogna, F Dalgard, D Linder, A Ewers, AY Finlay |
| 401 |
[GO] |
2020―Jun―04 |
Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas? |
AM Rosell-Díaz, A Mateos-Mayo, LM Nieto-Benito, I Balaguer-Franch, E Hernández de, A Laínez-Nuez, R Suárez-Fernández, M Bergón-Sendín |
| 402 |
[GO] |
2020―Jun―04 |
Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report |
H. Hashizume, Y. Sano, S. Furukawa, S. Imokawa |
| 403 |
[GO] |
2020―Jun―04 |
Iatrogenic dermatitis in times of COVID-19: A pandemic within a pandemic |
Riti Bhatia, Tekumalla Sindhuja, Saurabh Bhatia, Tanvi Dev, Atula Gupta, Meenu Bajpai, Somesh Gupta |
| 404 |
[GO] |
2020―Jun―04 |
Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients. |
A Reymundo, A Fernáldez-Bernáldez, A Reolid, B Butrón, P Fernández-Rico, P Muñoz-Hernández, D De Argila, M Llamas-Velasco |
| 405 |
[GO] |
2020―Jun―03 |
No antibody response in acral cutaneous manifestations associated with COVID-19 ? |
Rafael Mahieu, Lila Tillard, Hélène Le Guillou-Guillemette, Emeline Vinatier, Pascale Jeannin, Anne Croué, Yannick Le Corre, Yves-Marie Vandamme |
| 406 |
[GO] |
2020―Jun―03 |
Retiform purpura as a dermatological sign of covid-19 coagulopathy |
X Bosch-Amate, P Giavedoni, S Podlipnik, C Andreu-Febrer, J Sanz-Beltran, A Garcia-Herrera, L Alós, JM Mascaró |
| 407 |
[GO] |
2020―Jun―03 |
Pitfalls of possible reporting of same patients with COVID-19 in dermatology journals |
Nicolas Kluger |
| 408 |
[GO] |
2020―Jun―03 |
Acro-ischemia and COVID-19 infection: clinical and histopathological features |
J Calvão, M Relvas, A Pinho, A Brinca, J.C. Cardoso |
| 409 |
[GO] |
2020―Jun―03 |
Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice |
L. Sacchelli, F. Viviani, G. Orioni, P. Rucci, S. Rosa, A. Lanzoni, A. Patrizi, V. Gaspari |
| 410 |
[GO] |
2020―Jun―03 |
COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy |
Valeria Gaspari, Iria Neri, Cosimo Misciali, Annalisa Patrizi |
| 411 |
[GO] |
2020―Jun―03 |
Hand Eczema Pandemic Caused by SARS-CoV-2 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital Personnel |
K. Greveling, A.C.M. Kunkeler |
| 412 |
[GO] |
2020―Jun―03 |
Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic |
Atul Bothra, Seujee Das, Mehak Singh, Manoj Pawar, Anshu Maheswari |
| 413 |
[GO] |
2020―May―31 |
A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection |
M. El Hachem, A. Diociaiuti, C. Concato, R. Carsetti, C. Carnevale, M. Ciofi Degli Atti, L. Giovannelli, E. Latella, O. Porzio, S. Rossi, A. Stracuzzi, S. Zaffina, A. Onetti Muda, G. Zambruno, R. Alaggio |
| 414 |
[GO] |
2020―May―26 |
Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19) |
M. Dominguez-Santas, B. Diaz-Guimaraens, P. Garcia Abellas, C. Moreno-Garcia del Real, P. Burgos-Blasco, A. Suarez-Valle |
| 415 |
[GO] |
2020―May―26 |
COVID-19 in a melanoma patient under treatment with checkpoint inhibition |
P. Schmidle, T. Biedermann, C. Posch |
| 416 |
[GO] |
2020―May―26 |
Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children |
P. Labé, A. Ly, C. Sin, M. Nasser, E. Chapelon-Fromont, P. Ben Saïd, E. Mahé |
| 417 |
[GO] |
2020―May―26 |
The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities |
E. Rossi, M. Trakatelli, L. Giacomelli, B. Ferrari, M. Francomano, G. Pellacani, C. Magnoni |
| 418 |
[GO] |
2020―May―26 |
A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue |
I. Torres-Navarro, C. Abril-Pérez, J. Roca-Ginés, J. Sánchez-Arráez, R. Botella-Estrada |
| 419 |
[GO] |
2020―May―26 |
Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review |
A. Docampo-Simón, M.J. Sánchez-Pujol, G. Juan-Carpena, J.C. Palazón-Cabanes, E. Vergara-De Caso, L. Berbegal, I. Poveda-Montoyo, N. Pastor-Tomás, J. Mataix-Díaz, C. Terencio-Alemany, A. Martínez-Torres, J. Miralles-Botella, M. Blanes-Martínez, I. González-Villanueva, I. Betlloch-Mas |
| 420 |
[GO] |
2020―May―26 |
Coronavirus 19 presenting with atypical Sweet's syndrome |
B. Taşkın, S. Vural, E. Altuğ, C. Demirkesen, E. Kocatürk, İ. Çelebi, B. Ferhanoğlu, S. Alper |
| 421 |
[GO] |
2020―May―26 |
Late onset of acral necrosis after SARS-CoV-2 infection resolution |
R. Balestri, S. Termine, G. Rech, C.R. Girardelli |
| 422 |
[GO] |
2020―May―22 |
Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19 |
C. Guarneri, E. Venanzi Rullo, R. Gallizzi, M. Ceccarelli, S.P. Cannavò, G. Nunnari |
| 423 |
[GO] |
2020―May―22 |
COVID-19 and its implications for Dermatology and Venereology |
J. Ring |
| 424 |
[GO] |
2020―May―22 |
Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report |
A Mayor-Ibarguren, M Feito-Rodriguez, L Quintana Castanedo, E Ruiz-Bravo, D Montero Vega, P Herranz-Pinto |
| 425 |
[GO] |
2020―May―22 |
Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China |
H. Long, H. Zhao, A. Chen, Z. Yao, B. Cheng, Q. Lu |
| 426 |
[GO] |
2020―May―20 |
Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic |
MF García-Gil, M García García, J Monte Serrano, L Prieto-Torres, M Ara-Martín |
| 427 |
[GO] |
2020―May―19 |
COVID-19 and Dermatology: A Comprehensive Guide for Dermatologists |
Dina Hassan Fahmy, Heba Saed El-Amawy, Marwa Ahmed El-Samongy, Aya Ashraf Foud, Sarah Hamdy Soliman, Aya El-Kady, Francesca Farnetani, Andrea Conti, Ahmed Zoeir, Ahmed Eissa, Radwa Eissa, Stefano Puliatti, Maria Chiara Sighinolfi, Bernardo Rocco, Giovanni Pellacani |
| 428 |
[GO] |
2020―May―19 |
Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit |
Pietro Quaglino, Paolo Fava, Matteo Brizio, Elena Marra, Marco Rubatto, Andrea Agostini, Luca Tonella, Simone Ribero, Maria Teresa Fierro |
| 429 |
[GO] |
2020―May―19 |
A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema |
M Herrero-Moyano, TM Capusan, M Andreu-Barasoain, J Alcántara-González, M Ruano-Del Salado, ME Sánchez-Largo Uceda, L Calzado-Villarreal, Y Pérez-González |
| 430 |
[GO] |
2020―May―19 |
Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions? |
M Goldust, A Abdelmaksoud, Z Shuang, C Xiang, AA Navarini |
| 431 |
[GO] |
2020―May―18 |
Teledermatology for COVID-19 cutaneous lesions: substitute or supplement? |
C Skayem, C Cassius, M Ben Kahla, C Fiani, L Frumholtz, M Mrad, A Petit, E Zuelgaray, M Bagot, JD Bouaziz, TA Duong |
| 432 |
[GO] |
2020―May―18 |
A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect? |
N. Skroza, N. Bernardini, V. Balduzzi, A. Mambrin, A. Marchesiello, S. Michelini, E. Tolino, I. Proietti, C. Di Cristofano, V. Petrozza, C. Potenza |
| 433 |
[GO] |
2020―May―18 |
Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled study |
Liyun Dong, Liu Yang, Yan Li, Jing Yang, Xiangjie An, Liu Yang, Nuoya Zhou, Yamin Zhang, Hongyao Du, Jiajia Lan, Zexing Song, Xiaoping Miao, Jintao Zhu, Juan Tao |
| 434 |
[GO] |
2020―May―16 |
Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines Maarten Vermeer |
Evangelia Papadavid, Julia Scaribrick, Pablo Ortiz Romero, Pietro Guaglino, Maarten Vermeer, Robert Knobler, Rudolf Stadler, Martine Bagot |
| 435 |
[GO] |
2020―May―12 |
Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 cases |
Mehak Singh, Manoj Pawar, Atul Bothra, Anshu Maheshwari, Vivek Dubey, Apoorv Tiwari, Awatef Kelati |
| 436 |
[GO] |
2020―May―09 |
Dermatologic Surgery Training during the COVID-19 era |
José Alberto García-Lozano, Adrian Cuellar-Barboza, Verónica Garza-Rodríguez, Osvaldo Vázquez-Martínez, Jorge Ocampo-Candiani |
| 437 |
[GO] |
2020―May―09 |
Reply to “Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection”: Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation |
Pedro Rodríguez-Jiménez, Pablo Chicharro, Diego De Argila, Patricia Muñoz-Hernández, Mar Llamas-Velasco |
| 438 |
[GO] |
2020―May―09 |
Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia |
Catherine Gunawan, Allen Widysanto |
| 439 |
[GO] |
2020―May―09 |
Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemic |
V Campbell, D Middleton, J Donnelly, H Hunter |
| 440 |
[GO] |
2020―May―09 |
Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient |
A.G. Locatelli, E. Robustelli Test, P. Vezzoli, A. Carugno, E. Moggio, L. Consonni, A Gianatti, P. Sena |
| 441 |
[GO] |
2020―May―09 |
“Toxic erythema” and eosinophilia associated to tocilizumab therapy in a COVID-19 patient |
A Sernicola, G Carnicelli, M Di Fraia, C Chello, C Furlan, R Muharremi, G Paolino, T Grieco |
| 442 |
[GO] |
2020―May―09 |
COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management |
Cristina Mugheddu, Laura Pizzatti, Silvia Sanna, Laura Atzori, Franco Rongioletti |
| 443 |
[GO] |
2020―May―09 |
Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman |
E. Robustelli Test, P. Vezzoli, A. Carugno, F. Raponi, A. Gianatti, F. Rongioletti, P. Sena |
| 444 |
[GO] |
2020―May―09 |
Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2 |
Hicham Janah, Ali Zinebi, Jalal Elbenaye |
| 445 |
[GO] |
2020―May―09 |
SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab |
Francesca Caroppo, Giulia Biolo, Anna Belloni Fortina |
| 446 |
[GO] |
2020―May―07 |
Drug-induced vasculitis in a patient with COVID-19 |
A. Vanegas Ramirez, D. Efe, M. Fischer |
| 447 |
[GO] |
2020―May―07 |
Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs |
A. Conti, C. Lasagni, L. Bigi, G. Pellacani |
| 448 |
[GO] |
2020―May―07 |
Acro-ischemia in hospitalized COVID-19 patients |
A. Suarez-Valle, D. Fernandez-Nieto, B. Diaz-Guimaraens, M. Dominguez-Santas, I. Carretero, B. Perez-Garcia |
| 449 |
[GO] |
2020―May―07 |
Symmetric cutaneous vasculitis in COVID-19 pneumonia |
Laura Castelnovo, Francesca Capelli, Antonio Tamburello, Paola Maria Faggioli, Antonino Mazzone |
| 450 |
[GO] |
2020―May―07 |
SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes |
M Delfino, M Guida, A Patrì, L Spirito, L Gallo, G Fabbrocini |
| 451 |
[GO] |
2020―May―07 |
Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient |
F. Benhadou, V. Del Marmol |
| 452 |
[GO] |
2020―May―03 |
Hand disinfection in the combat against Covid-19 |
M Goldust, A Abdelmaksoud, AA Navarini |
| 453 |
[GO] |
2020―May―03 |
Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model |
Antonio Tejera-Vaquerizo, Eduardo Nagore |
| 454 |
[GO] |
2020―May―03 |
Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients |
Shiyao Pei, Yadong Xue, Shuang Zhao, Navarini Alexander, Goldust Mohamad, Xiang Chen, Mingzhu Yin |
| 455 |
[GO] |
2020―May―02 |
COVID-19 epidemic: Skin protection for health care workers must not be ignored |
Bin Zhang, Ruijie Zhai, Lin Ma |
| 456 |
[GO] |
2020―May―02 |
Histological pattern in Covid-19 induced viral rash |
Corrado Zengarini, Gionathan Orioni, Alessandra Cascavilla, Clara Horna Solera, Ciro Fulgaro, Cosimo Misciali, Annalisa Patrizi, Valeria Gaspari |
| 457 |
[GO] |
2020―May―02 |
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection |
Amir Hooshang Ehsani, Maryam Nasimi, Zeinab Bigdelo |
| 458 |
[GO] |
2020―May―02 |
The use of Google trends for acral symptoms during COVID-19 outbreak in France |
Nicolas Kluger, Yannis Scrivener |
| 459 |
[GO] |
2020―May―02 |
Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus |
R. Balestri, G. Rech, C.R. Girardelli |
| 460 |
[GO] |
2020―May―02 |
SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor |
R. Balestri, G. Rech, C.R. Girardelli |
| 461 |
[GO] |
2020―May―01 |
European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions |
Anna Balato, Fabio Ayala, Magnus Bruze, Marie-Noëlle Crepy, Margarida Gonçalo, Jeanne Duus Johansen, Swen Malte John, Paolo Pigatto, Annunziata Raimondo, Thomas Rustemeyer, Marie-Louise A. Schuttelaar, Cecilia Svedman, Olivier Aerst, Wolfgang Uter, Mark Wilkinson, Anamaria Gimenez-Arnau |
| 462 |
[GO] |
2020―Apr―27 |
No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy |
A. Carugno, F. Raponi, A.G. Locatelli, P. Vezzoli, D.M. Gambini, M. Di Mercurio, E. Robustelli Test, P. Sena |
| 463 |
[GO] |
2020―Apr―27 |
Vascular skin symptoms in COVID-19: a french observational study |
JD Bouaziz, T Duong, M Jachiet, C Velter, P Lestang, C Cassius, A Arsouze, E Domergue Than Trong, M Bagot, E Begon, L Sulimovic, M Rybojad |
| 464 |
[GO] |
2020―Apr―25 |
Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic |
M. Kasperkiewicz, E. Schmidt, J.A. Fairley, P. Joly, A.S. Payne, M.L. Yale, D. Zillikens, D.T. Woodley |
| 465 |
[GO] |
2020―Apr―25 |
Skin cancer triage and management during COVID-19 pandemic |
Luca Tagliaferri, Alessandro Di Stefani, Giovanni Schinzari, Bruno Fionda, Ernesto Rossi, Laura Del Regno, Stefano Gentileschi, Francesco Federico, Vincenzo Valentini, Giampaolo Tortora, Ketty Peris |
| 466 |
[GO] |
2020―Apr―24 |
Acral cutaneous lesions in the Time of COVID-19 |
S. Recalcati, T. Barbagallo, L.A. Frasin, F. Prestinari, A. Cogliardi, M.C. Provero, E. Dainese, A. Vanzati, F. Fantini |
| 467 |
[GO] |
2020―Apr―24 |
Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients |
Vincenzo Piccolo, Iria Neri, Cesare Filippeschi, Teresa Oranges, Giuseppe Argenziano, Vincenzo Claudio Battarra, Samantha Berti, Francesca Manunza, Anna Belloni Fortina, Vito Di Lernia, Valeria Boccaletti, Giovanna De Bernardis, Bruno Brunetti, Carlo Mazzatenta, Andrea Bassi |
| 468 |
[GO] |
2020―Apr―24 |
Cutaneous manifestation of COVID-19 in images: A case report |
R. Avellana Moreno, Estela Villa, V. Avellana Moreno, C. Estela Villa, Moreno Aparicio, Avellana Fontanella |
| 469 |
[GO] |
2020―Apr―24 |
Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection |
C. van Damme, E. Berlingin, S. Saussez, O. Accaputo |
| 470 |
[GO] |
2020―Apr―24 |
Did Whatsapp
®
reveal a new cutaneous COVID-19 manifestation? |
TA Duong, C Velter, M Rybojad, C Comte, M Bagot, L Sulimovic, JD Bouaziz |
| 471 |
[GO] |
2020―Apr―24 |
Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studies |
S. Garcovich, F.S Bersani, A. Chiricozzi, C. De Simone |
| 472 |
[GO] |
2020―Apr―24 |
Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome |
A. Tammaro, G.A.R. Adebanjo, F.R. Parisella, A. Pezzuto, J. Rello |
| 473 |
[GO] |
2020―Apr―24 |
Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports |
S. Ferrucci, M. Romagnuolo, L. Angileri, E. Berti, S. Tavecchio |
| 474 |
[GO] |
2020―Apr―24 |
SARS-CoV-2 infection presenting as a febrile rash |
F Amatore, N Macagno, M Mailhe, B Demarez, C Gaudy-Marqueste, JJ Grob, D Raoult, P Brouqui, MA Richard |
| 475 |
[GO] |
2020―Apr―22 |
Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice |
P Gisondi, S Piaserico, A Conti, L Naldi |
| 476 |
[GO] |
2020―Apr―21 |
Comment on “Cutaneous manifestations in COVID-19: a first perspective ” by Recalcati S |
M. Hedou, F. Carsuzaa, E. Chary, E. Hainaut, F. Cazenave-Roblot, M. Masson Regnault |
| 477 |
[GO] |
2020―Apr―17 |
Skin Reactions to Non-glove Personal Protective Equipment: An Emerging Issue in the COVID-19 Pandemic |
Mehdi Gheisari, Farnaz Araghi, Hamideh Moravvej, Mohammadreza Tabary, Sahar Dadkhahfar |
| 478 |
[GO] |
2020―Apr―17 |
Covid-19: Countermeasure for N95 mask-induced pressure sore |
ZhiQiang Yin |
| 479 |
[GO] |
2020―Apr―17 |
Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? |
Ambra Di Altobrando, Annalisa Patrizi, Federico Bardazzi |
| 480 |
[GO] |
2020―Apr―15 |
Viral exanthem in COVID-19, a clinical enigma with biological significance |
Chia-Jui Su, Chih-Hung Lee |
| 481 |
[GO] |
2020―Apr―15 |
COVID-19 and Cutaneous manifestations |
Rujittika Mungmungpuntipantip, Viroj Wiwanitkit |
| 482 |
[GO] |
2020―Apr―15 |
Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic |
C. Marasca, A. Ruggiero, M.C. Annunziata, G. Fabbrocini, M. Megna |
| 483 |
[GO] |
2020―Apr―15 |
Urticarial eruption in COVID-19 infection |
D. Henry, M. Ackerman, E. Sancelme, A. Finon, E. Esteve |
| 484 |
[GO] |
2020―Apr―15 |
Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies |
D Fernandez-Nieto, D Ortega-Quijano, G Segurado-Miravalles, C Pindado-Ortega, M Prieto-Barrios, J Jimenez-Cauhe |
| 485 |
[GO] |
2020―Apr―15 |
Cutaneous manifestations in COVID-19: a new contribution |
Andrea Estébanez, Leticia Pérez-Santiago, Esmeralda Silva, Santiago Guillen-Climent, Alejandro García-Vázquez, M. Dolores Ramón |
| 486 |
[GO] |
2020―Apr―15 |
A distinctive skin rash associated with Coronavirus Disease 2019 ? |
A. Mahé, E. Birckel, S. Krieger, C. Merklen, L. Bottlaender |
| 487 |
[GO] |
2020―Apr―15 |
Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy) |
L. Atzori, C. Mugheddu, G. Addis, S. Sanna, R. Satta, C. Ferreli, M.G. Atzori, M.A. Montesu, F. Rongioletti |
| 488 |
[GO] |
2020―Apr―15 |
SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor |
F. Messina, S. Piaserico |
| 489 |
[GO] |
2020―Mar―29 |
Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day! |
Deepak Jakhar, Ishmeet Kaur, Subuhi Kaul |
| 490 |
[GO] |
2020―Mar―29 |
European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis |
Andreas Wollenberg, Carsten Flohr, Dagmar Simon, Michael J Cork, Jacob P. Thyssen, Thomas Bieber, Marjolein S. de Bruin-Weller, Stephan Weidinger, Mette Deleuran, Alain Taieb, Carle Paul, Magdalena Trzeciak, Thomas Werfel, Julien Seneschal, Sebastien Barbarot, Ulf Darsow, Antonio Torrelo, Jean-Francois Stalder, Åke Svensson, Dirkjan Hijnen, Carlo Gelmetti, Zsuzsanna Szalai, Uwe Gieler, Linda De Raeve, Barbara Kunz, Phyllis Spuls, Laura B von Kobyletzki, Regina Fölster-Holst, Pavel V. Chernyshov, Stéphanie Cristen-Zaech, Annice Heratizadeh, Johannes Ring, Christian Vestergaard |
| 491 |
[GO] |
2020―Mar―27 |
What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist’s perspective from China |
Hanlin Zhang, Keyun Tang, Rouyu Fang, Qiuning Sun |
| 492 |
[GO] |
2020―Mar―27 |
Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances |
M Reinholz, LE French |
| 493 |
[GO] |
2020―Mar―26 |
Cutaneous manifestations in COVID-19: a first perspective |
S. Recalcati |
| 494 |
[GO] |
2020―Mar―23 |
Dermatology staff participate in fight against Covid-19 in China |
Yue Zheng, Wei Lai |
| 495 |
[GO] |
2020―Mar―23 |
Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital |
G. Radi, F. Diotallevi, A. Campanati, A. Offidani |
|
